Reunió 20/10/2020
Lípid de referencia: PI 38:4
Resultats PI 38:4 Sa High vs Tumor High
Cluster Sample
Determinació Beta
Cluster gens
Correlació mòduls i fenotips
Gens drivers dels mòduls associats al fenotip
GO
Es mostren els 10 millors GO
| X | module | size | p.val | Bonf | nInTerm | GO.id | ont | term.name |
|---|---|---|---|---|---|---|---|---|
| 1 | antiquewhite2 | 45 | 2.0e-05 | 0.360 | 2 | GO:0015245 | MF | fatty acid transmembrane transporter activity |
| 2 | antiquewhite2 | 45 | 6.9e-04 | 1.000 | 3 | GO:0046470 | BP | phosphatidylcholine metabolic process |
| 3 | antiquewhite2 | 45 | 1.5e-03 | 1.000 | 2 | GO:0008028 | MF | monocarboxylic acid transmembrane transporter activity |
| 4 | antiquewhite2 | 45 | 2.0e-03 | 1.000 | 3 | GO:0052689 | MF | carboxylic ester hydrolase activity |
| 5 | antiquewhite2 | 45 | 2.6e-03 | 1.000 | 1 | GO:0006580 | BP | ethanolamine metabolic process |
| 6 | antiquewhite2 | 45 | 2.6e-03 | 1.000 | 1 | GO:0015730 | BP | propanoate transport |
| 7 | antiquewhite2 | 45 | 2.6e-03 | 1.000 | 1 | GO:0015913 | BP | short-chain fatty acid import |
| 8 | antiquewhite2 | 45 | 2.6e-03 | 1.000 | 1 | GO:1903676 | BP | positive regulation of cap-dependent translational initiation |
| 9 | antiquewhite2 | 45 | 2.6e-03 | 1.000 | 1 | GO:1904681 | BP | response to 3-methylcholanthrene |
| 10 | antiquewhite2 | 45 | 2.6e-03 | 1.000 | 1 | GO:0015552 | MF | propionate transmembrane transporter activity |
| 11 | antiquewhite4 | 61 | 3.4e-04 | 1.000 | 2 | GO:0003190 | BP | atrioventricular valve formation |
| 12 | antiquewhite4 | 61 | 1.1e-03 | 1.000 | 2 | GO:0003188 | BP | heart valve formation |
| 13 | antiquewhite4 | 61 | 1.1e-03 | 1.000 | 2 | GO:0015919 | BP | peroxisomal membrane transport |
| 14 | antiquewhite4 | 61 | 1.6e-03 | 1.000 | 3 | GO:0006625 | BP | protein targeting to peroxisome |
| 15 | antiquewhite4 | 61 | 1.6e-03 | 1.000 | 3 | GO:0072663 | BP | establishment of protein localization to peroxisome |
| 16 | antiquewhite4 | 61 | 1.9e-03 | 1.000 | 3 | GO:1900407 | BP | regulation of cellular response to oxidative stress |
| 17 | antiquewhite4 | 61 | 2.5e-03 | 1.000 | 3 | GO:0007031 | BP | peroxisome organization |
| 18 | antiquewhite4 | 61 | 2.7e-03 | 1.000 | 3 | GO:1902882 | BP | regulation of response to oxidative stress |
| 19 | antiquewhite4 | 61 | 3.0e-03 | 1.000 | 2 | GO:0003181 | BP | atrioventricular valve morphogenesis |
| 20 | antiquewhite4 | 61 | 3.8e-03 | 1.000 | 5 | GO:0007599 | BP | hemostasis |
| 21 | bisque4 | 79 | 5.5e-04 | 1.000 | 2 | GO:0045906 | BP | negative regulation of vasoconstriction |
| 22 | bisque4 | 79 | 4.3e-03 | 1.000 | 2 | GO:0050901 | BP | leukocyte tethering or rolling |
| 23 | bisque4 | 79 | 4.8e-03 | 1.000 | 2 | GO:0061037 | BP | negative regulation of cartilage development |
| 24 | bisque4 | 79 | 4.8e-03 | 1.000 | 2 | GO:2000765 | BP | regulation of cytoplasmic translation |
| 25 | bisque4 | 79 | 5.2e-03 | 1.000 | 1 | GO:0006540 | BP | glutamate decarboxylation to succinate |
| 26 | bisque4 | 79 | 5.2e-03 | 1.000 | 1 | GO:0035921 | BP | desmosome disassembly |
| 27 | bisque4 | 79 | 5.2e-03 | 1.000 | 1 | GO:0036261 | BP | 7-methylguanosine cap hypermethylation |
| 28 | bisque4 | 79 | 5.2e-03 | 1.000 | 1 | GO:0043048 | BP | dolichyl monophosphate biosynthetic process |
| 29 | bisque4 | 79 | 5.2e-03 | 1.000 | 1 | GO:0061881 | BP | positive regulation of anterograde axonal transport of mitochondrion |
| 30 | bisque4 | 79 | 5.2e-03 | 1.000 | 1 | GO:0071298 | BP | cellular response to L-ascorbic acid |
| 31 | black | 549 | 3.4e-04 | 1.000 | 87 | GO:0016787 | MF | hydrolase activity |
| 32 | black | 549 | 4.5e-04 | 1.000 | 3 | GO:1990511 | BP | piRNA biosynthetic process |
| 33 | black | 549 | 4.5e-04 | 1.000 | 3 | GO:0004523 | MF | RNA-DNA hybrid ribonuclease activity |
| 34 | black | 549 | 5.2e-04 | 1.000 | 7 | GO:0004521 | MF | endoribonuclease activity |
| 35 | black | 549 | 7.3e-04 | 1.000 | 28 | GO:0005813 | CC | centrosome |
| 36 | black | 549 | 8.7e-04 | 1.000 | 3 | GO:0030854 | BP | positive regulation of granulocyte differentiation |
| 37 | black | 549 | 1.3e-03 | 1.000 | 2 | GO:0045645 | BP | positive regulation of eosinophil differentiation |
| 38 | black | 549 | 1.3e-03 | 1.000 | 40 | GO:0008270 | MF | zinc ion binding |
| 39 | black | 549 | 1.3e-03 | 1.000 | 13 | GO:0004518 | MF | nuclease activity |
| 40 | black | 549 | 1.7e-03 | 1.000 | 9 | GO:1901216 | BP | positive regulation of neuron death |
| 41 | blue | 939 | 7.2e-04 | 1.000 | 5 | GO:0060716 | BP | labyrinthine layer blood vessel development |
| 42 | blue | 939 | 8.2e-04 | 1.000 | 50 | GO:0055082 | BP | cellular chemical homeostasis |
| 43 | blue | 939 | 8.7e-04 | 1.000 | 3 | GO:0072014 | BP | proximal tubule development |
| 44 | blue | 939 | 9.3e-04 | 1.000 | 25 | GO:0045927 | BP | positive regulation of growth |
| 45 | blue | 939 | 9.4e-04 | 1.000 | 7 | GO:0071870 | BP | cellular response to catecholamine stimulus |
| 46 | blue | 939 | 1.3e-03 | 1.000 | 19 | GO:0030324 | BP | lung development |
| 47 | blue | 939 | 1.6e-03 | 1.000 | 41 | GO:0006873 | BP | cellular ion homeostasis |
| 48 | blue | 939 | 1.7e-03 | 1.000 | 40 | GO:0030003 | BP | cellular cation homeostasis |
| 49 | blue | 939 | 1.7e-03 | 1.000 | 19 | GO:0030323 | BP | respiratory tube development |
| 50 | blue | 939 | 1.8e-03 | 1.000 | 7 | GO:0060428 | BP | lung epithelium development |
| 51 | blue2 | 55 | 1.3e-05 | 0.230 | 7 | GO:0030522 | BP | intracellular receptor signaling pathway |
| 52 | blue2 | 55 | 7.6e-05 | 1.000 | 3 | GO:0007094 | BP | mitotic spindle assembly checkpoint |
| 53 | blue2 | 55 | 9.7e-05 | 1.000 | 3 | GO:0045841 | BP | negative regulation of mitotic metaphase/anaphase transition |
| 54 | blue2 | 55 | 1.2e-04 | 1.000 | 2 | GO:0005749 | CC | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) |
| 55 | blue2 | 55 | 1.2e-04 | 1.000 | 2 | GO:0045273 | CC | respiratory chain complex II |
| 56 | blue2 | 55 | 1.8e-04 | 1.000 | 3 | GO:0001221 | MF | transcription cofactor binding |
| 57 | blue2 | 55 | 3.1e-04 | 1.000 | 3 | GO:0030071 | BP | regulation of mitotic metaphase/anaphase transition |
| 58 | blue2 | 55 | 3.1e-04 | 1.000 | 3 | GO:0045839 | BP | negative regulation of mitotic nuclear division |
| 59 | blue2 | 55 | 3.8e-04 | 1.000 | 3 | GO:0007091 | BP | metaphase/anaphase transition of mitotic cell cycle |
| 60 | blue2 | 55 | 3.8e-04 | 1.000 | 3 | GO:0010965 | BP | regulation of mitotic sister chromatid separation |
| 61 | blue4 | 29 | 1.9e-03 | 1.000 | 1 | GO:0060981 | BP | cell migration involved in coronary angiogenesis |
| 62 | blue4 | 29 | 1.9e-03 | 1.000 | 1 | GO:0072277 | BP | metanephric glomerular capillary formation |
| 63 | blue4 | 29 | 1.9e-03 | 1.000 | 1 | GO:1903435 | BP | positive regulation of constitutive secretory pathway |
| 64 | blue4 | 29 | 1.9e-03 | 1.000 | 1 | GO:0070176 | CC | DRM complex |
| 65 | blue4 | 29 | 1.9e-03 | 1.000 | 1 | GO:0033791 | MF | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| 66 | blue4 | 29 | 1.9e-03 | 1.000 | 1 | GO:0047166 | MF | 1-alkenylglycerophosphoethanolamine O-acyltransferase activity |
| 67 | blue4 | 29 | 1.9e-03 | 1.000 | 1 | GO:0047992 | MF | hydroxylysine kinase activity |
| 68 | blue4 | 29 | 2.5e-03 | 1.000 | 2 | GO:0008206 | BP | bile acid metabolic process |
| 69 | blue4 | 29 | 3.5e-03 | 1.000 | 3 | GO:0030258 | BP | lipid modification |
| 70 | blue4 | 29 | 3.7e-03 | 1.000 | 6 | GO:0044255 | BP | cellular lipid metabolic process |
| 71 | blueviolet | 29 | 2.0e-03 | 1.000 | 1 | GO:0032203 | BP | telomere formation via telomerase |
| 72 | blueviolet | 29 | 2.0e-03 | 1.000 | 1 | GO:0034130 | BP | toll-like receptor 1 signaling pathway |
| 73 | blueviolet | 29 | 2.0e-03 | 1.000 | 1 | GO:0034337 | BP | RNA folding |
| 74 | blueviolet | 29 | 2.0e-03 | 1.000 | 1 | GO:1904867 | BP | protein localization to Cajal body |
| 75 | blueviolet | 29 | 2.0e-03 | 1.000 | 1 | GO:1990678 | BP | histone H4-K16 deacetylation |
| 76 | blueviolet | 29 | 2.0e-03 | 1.000 | 1 | GO:0033961 | MF | cis-stilbene-oxide hydrolase activity |
| 77 | blueviolet | 29 | 2.0e-03 | 1.000 | 1 | GO:0052381 | MF | tRNA dimethylallyltransferase activity |
| 78 | blueviolet | 29 | 2.4e-03 | 1.000 | 3 | GO:0010594 | BP | regulation of endothelial cell migration |
| 79 | blueviolet | 29 | 2.8e-03 | 1.000 | 2 | GO:0006111 | BP | regulation of gluconeogenesis |
| 80 | blueviolet | 29 | 3.2e-03 | 1.000 | 2 | GO:0010830 | BP | regulation of myotube differentiation |
| 81 | brown | 903 | 3.3e-04 | 1.000 | 17 | GO:0001889 | BP | liver development |
| 82 | brown | 903 | 8.0e-04 | 1.000 | 99 | GO:0009967 | BP | positive regulation of signal transduction |
| 83 | brown | 903 | 8.0e-04 | 1.000 | 3 | GO:0047498 | MF | calcium-dependent phospholipase A2 activity |
| 84 | brown | 903 | 1.0e-03 | 1.000 | 7 | GO:0010092 | BP | specification of animal organ identity |
| 85 | brown | 903 | 1.8e-03 | 1.000 | 15 | GO:0014065 | BP | phosphatidylinositol 3-kinase signaling |
| 86 | brown | 903 | 1.9e-03 | 1.000 | 5 | GO:0001779 | BP | natural killer cell differentiation |
| 87 | brown | 903 | 1.9e-03 | 1.000 | 5 | GO:0102567 | MF | phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) |
| 88 | brown | 903 | 1.9e-03 | 1.000 | 5 | GO:0102568 | MF | phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) |
| 89 | brown | 903 | 2.0e-03 | 1.000 | 4 | GO:0033197 | BP | response to vitamin E |
| 90 | brown | 903 | 2.0e-03 | 1.000 | 4 | GO:0048853 | BP | forebrain morphogenesis |
| 91 | brown2 | 61 | 9.4e-04 | 1.000 | 3 | GO:0032722 | BP | positive regulation of chemokine production |
| 92 | brown2 | 61 | 1.2e-03 | 1.000 | 2 | GO:1902187 | BP | negative regulation of viral release from host cell |
| 93 | brown2 | 61 | 1.9e-03 | 1.000 | 4 | GO:0030307 | BP | positive regulation of cell growth |
| 94 | brown2 | 61 | 2.2e-03 | 1.000 | 4 | GO:0030017 | CC | sarcomere |
| 95 | brown2 | 61 | 2.5e-03 | 1.000 | 3 | GO:0032642 | BP | regulation of chemokine production |
| 96 | brown2 | 61 | 2.9e-03 | 1.000 | 7 | GO:0019901 | MF | protein kinase binding |
| 97 | brown2 | 61 | 3.0e-03 | 1.000 | 3 | GO:0032602 | BP | chemokine production |
| 98 | brown2 | 61 | 3.2e-03 | 1.000 | 12 | GO:0006952 | BP | defense response |
| 99 | brown2 | 61 | 3.3e-03 | 1.000 | 4 | GO:0030016 | CC | myofibril |
| 100 | brown2 | 61 | 3.7e-03 | 1.000 | 8 | GO:0042803 | MF | protein homodimerization activity |
| 101 | brown4 | 88 | 2.0e-04 | 1.000 | 2 | GO:0005384 | MF | manganese ion transmembrane transporter activity |
| 102 | brown4 | 88 | 3.2e-04 | 1.000 | 2 | GO:0008131 | MF | primary amine oxidase activity |
| 103 | brown4 | 88 | 4.9e-04 | 1.000 | 2 | GO:0006828 | BP | manganese ion transport |
| 104 | brown4 | 88 | 4.9e-04 | 1.000 | 2 | GO:0071421 | BP | manganese ion transmembrane transport |
| 105 | brown4 | 88 | 6.0e-04 | 1.000 | 4 | GO:0070062 | CC | extracellular exosome |
| 106 | brown4 | 88 | 7.4e-04 | 1.000 | 3 | GO:1904646 | BP | cellular response to amyloid-beta |
| 107 | brown4 | 88 | 9.6e-04 | 1.000 | 4 | GO:1903561 | CC | extracellular vesicle |
| 108 | brown4 | 88 | 1.5e-03 | 1.000 | 3 | GO:1904645 | BP | response to amyloid-beta |
| 109 | brown4 | 88 | 2.5e-03 | 1.000 | 3 | GO:0007588 | BP | excretion |
| 110 | brown4 | 88 | 2.5e-03 | 1.000 | 3 | GO:0030145 | MF | manganese ion binding |
| 111 | coral | 44 | 6.7e-04 | 1.000 | 2 | GO:0022616 | BP | DNA strand elongation |
| 112 | coral | 44 | 2.2e-03 | 1.000 | 3 | GO:0060048 | BP | cardiac muscle contraction |
| 113 | coral | 44 | 2.8e-03 | 1.000 | 1 | GO:1903723 | BP | negative regulation of centriole elongation |
| 114 | coral | 44 | 2.8e-03 | 1.000 | 1 | GO:0000285 | MF | 1-phosphatidylinositol-3-phosphate 5-kinase activity |
| 115 | coral | 44 | 2.8e-03 | 1.000 | 1 | GO:0005055 | MF | laminin receptor activity |
| 116 | coral | 44 | 2.8e-03 | 1.000 | 1 | GO:0033699 | MF | DNA 5’-adenosine monophosphate hydrolase activity |
| 117 | coral | 44 | 2.8e-03 | 1.000 | 1 | GO:0106105 | MF | Ala-tRNA(Thr) hydrolase activity |
| 118 | coral | 44 | 2.8e-03 | 1.000 | 1 | GO:0120108 | MF | DNA-3’-diphospho-5’-guanosine diphosphatase |
| 119 | coral | 44 | 2.8e-03 | 1.000 | 1 | GO:1990738 | MF | pseudouridine 5’-phosphatase activity |
| 120 | coral | 44 | 4.6e-03 | 1.000 | 5 | GO:0008015 | BP | blood circulation |
| 121 | coral1 | 58 | 1.5e-04 | 1.000 | 5 | GO:0030496 | CC | midbody |
| 122 | coral1 | 58 | 1.6e-03 | 1.000 | 6 | GO:0098797 | CC | plasma membrane protein complex |
| 123 | coral1 | 58 | 1.9e-03 | 1.000 | 3 | GO:0042058 | BP | regulation of epidermal growth factor receptor signaling pathway |
| 124 | coral1 | 58 | 2.1e-03 | 1.000 | 2 | GO:0090103 | BP | cochlea morphogenesis |
| 125 | coral1 | 58 | 2.4e-03 | 1.000 | 3 | GO:1901184 | BP | regulation of ERBB signaling pathway |
| 126 | coral1 | 58 | 2.8e-03 | 1.000 | 2 | GO:0007176 | BP | regulation of epidermal growth factor-activated receptor activity |
| 127 | coral1 | 58 | 3.6e-03 | 1.000 | 1 | GO:0021633 | BP | optic nerve structural organization |
| 128 | coral1 | 58 | 3.6e-03 | 1.000 | 1 | GO:0035566 | BP | regulation of metanephros size |
| 129 | coral1 | 58 | 3.6e-03 | 1.000 | 1 | GO:0061360 | BP | optic chiasma development |
| 130 | coral1 | 58 | 3.6e-03 | 1.000 | 1 | GO:0070367 | BP | negative regulation of hepatocyte differentiation |
| 131 | coral2 | 67 | 9.2e-04 | 1.000 | 2 | GO:0021521 | BP | ventral spinal cord interneuron specification |
| 132 | coral2 | 67 | 1.5e-03 | 1.000 | 3 | GO:0097194 | BP | execution phase of apoptosis |
| 133 | coral2 | 67 | 1.7e-03 | 1.000 | 2 | GO:0060579 | BP | ventral spinal cord interneuron fate commitment |
| 134 | coral2 | 67 | 2.2e-03 | 1.000 | 2 | GO:0021514 | BP | ventral spinal cord interneuron differentiation |
| 135 | coral2 | 67 | 2.2e-03 | 1.000 | 2 | GO:0042481 | BP | regulation of odontogenesis |
| 136 | coral2 | 67 | 2.8e-03 | 1.000 | 2 | GO:0044342 | BP | type B pancreatic cell proliferation |
| 137 | coral2 | 67 | 2.8e-03 | 1.000 | 5 | GO:0009593 | BP | detection of chemical stimulus |
| 138 | coral2 | 67 | 3.4e-03 | 1.000 | 2 | GO:0021513 | BP | spinal cord dorsal/ventral patterning |
| 139 | coral2 | 67 | 3.4e-03 | 1.000 | 2 | GO:0008305 | CC | integrin complex |
| 140 | coral2 | 67 | 3.7e-03 | 1.000 | 2 | GO:0021511 | BP | spinal cord patterning |
| 141 | coral3 | 41 | 7.5e-06 | 0.130 | 2 | GO:0106029 | MF | tRNA pseudouridine synthase activity |
| 142 | coral3 | 41 | 2.1e-04 | 1.000 | 2 | GO:0009982 | MF | pseudouridine synthase activity |
| 143 | coral3 | 41 | 4.5e-04 | 1.000 | 8 | GO:0006396 | BP | RNA processing |
| 144 | coral3 | 41 | 1.2e-03 | 1.000 | 2 | GO:0060390 | BP | regulation of SMAD protein signal transduction |
| 145 | coral3 | 41 | 1.6e-03 | 1.000 | 3 | GO:0097711 | BP | ciliary basal body-plasma membrane docking |
| 146 | coral3 | 41 | 1.9e-03 | 1.000 | 3 | GO:0008033 | BP | tRNA processing |
| 147 | coral3 | 41 | 2.3e-03 | 1.000 | 2 | GO:0030261 | BP | chromosome condensation |
| 148 | coral3 | 41 | 2.8e-03 | 1.000 | 1 | GO:0010085 | BP | polarity specification of proximal/distal axis |
| 149 | coral3 | 41 | 2.8e-03 | 1.000 | 1 | GO:0046318 | BP | negative regulation of glucosylceramide biosynthetic process |
| 150 | coral3 | 41 | 2.8e-03 | 1.000 | 1 | GO:0048327 | BP | axial mesodermal cell fate specification |
| 151 | cyan | 237 | 7.1e-04 | 1.000 | 3 | GO:0051131 | BP | chaperone-mediated protein complex assembly |
| 152 | cyan | 237 | 7.3e-04 | 1.000 | 7 | GO:0030968 | BP | endoplasmic reticulum unfolded protein response |
| 153 | cyan | 237 | 9.8e-04 | 1.000 | 8 | GO:0006986 | BP | response to unfolded protein |
| 154 | cyan | 237 | 1.1e-03 | 1.000 | 7 | GO:0034620 | BP | cellular response to unfolded protein |
| 155 | cyan | 237 | 1.4e-03 | 1.000 | 2 | GO:0016554 | BP | cytidine to uridine editing |
| 156 | cyan | 237 | 1.4e-03 | 1.000 | 5 | GO:0036498 | BP | IRE1-mediated unfolded protein response |
| 157 | cyan | 237 | 1.4e-03 | 1.000 | 3 | GO:0031643 | BP | positive regulation of myelination |
| 158 | cyan | 237 | 1.9e-03 | 1.000 | 4 | GO:0031641 | BP | regulation of myelination |
| 159 | cyan | 237 | 1.9e-03 | 1.000 | 4 | GO:0019894 | MF | kinesin binding |
| 160 | cyan | 237 | 2.0e-03 | 1.000 | 7 | GO:0035967 | BP | cellular response to topologically incorrect protein |
| 161 | darkgreen | 140 | 2.2e-04 | 1.000 | 6 | GO:0002687 | BP | positive regulation of leukocyte migration |
| 162 | darkgreen | 140 | 4.9e-04 | 1.000 | 3 | GO:0032682 | BP | negative regulation of chemokine production |
| 163 | darkgreen | 140 | 5.5e-04 | 1.000 | 8 | GO:0000086 | BP | G2/M transition of mitotic cell cycle |
| 164 | darkgreen | 140 | 9.1e-04 | 1.000 | 8 | GO:0044839 | BP | cell cycle G2/M phase transition |
| 165 | darkgreen | 140 | 1.1e-03 | 1.000 | 5 | GO:0097711 | BP | ciliary basal body-plasma membrane docking |
| 166 | darkgreen | 140 | 1.7e-03 | 1.000 | 9 | GO:0044782 | BP | cilium organization |
| 167 | darkgreen | 140 | 2.4e-03 | 1.000 | 6 | GO:0002685 | BP | regulation of leukocyte migration |
| 168 | darkgreen | 140 | 2.5e-03 | 1.000 | 4 | GO:0002690 | BP | positive regulation of leukocyte chemotaxis |
| 169 | darkgreen | 140 | 2.6e-03 | 1.000 | 11 | GO:0030031 | BP | cell projection assembly |
| 170 | darkgreen | 140 | 3.0e-03 | 1.000 | 5 | GO:0050921 | BP | positive regulation of chemotaxis |
| 171 | darkgrey | 123 | 2.6e-04 | 1.000 | 3 | GO:0010804 | BP | negative regulation of tumor necrosis factor-mediated signaling pathway |
| 172 | darkgrey | 123 | 3.8e-04 | 1.000 | 3 | GO:0010529 | BP | negative regulation of transposition |
| 173 | darkgrey | 123 | 9.5e-04 | 1.000 | 2 | GO:0045008 | BP | depyrimidination |
| 174 | darkgrey | 123 | 1.3e-03 | 1.000 | 2 | GO:0006285 | BP | base-excision repair, AP site formation |
| 175 | darkgrey | 123 | 1.3e-03 | 1.000 | 2 | GO:0140078 | MF | class I DNA-(apurinic or apyrimidinic site) endonuclease activity |
| 176 | darkgrey | 123 | 1.7e-03 | 1.000 | 2 | GO:0009223 | BP | pyrimidine deoxyribonucleotide catabolic process |
| 177 | darkgrey | 123 | 1.7e-03 | 1.000 | 2 | GO:0008331 | MF | high voltage-gated calcium channel activity |
| 178 | darkgrey | 123 | 2.2e-03 | 1.000 | 2 | GO:0003906 | MF | DNA-(apurinic or apyrimidinic site) endonuclease activity |
| 179 | darkgrey | 123 | 2.4e-03 | 1.000 | 4 | GO:0008170 | MF | N-methyltransferase activity |
| 180 | darkgrey | 123 | 2.8e-03 | 1.000 | 2 | GO:0019104 | MF | DNA N-glycosylase activity |
| 181 | darkmagenta | 100 | 2.6e-05 | 0.450 | 4 | GO:0048873 | BP | homeostasis of number of cells within a tissue |
| 182 | darkmagenta | 100 | 1.3e-04 | 1.000 | 2 | GO:0035585 | BP | calcium-mediated signaling using extracellular calcium source |
| 183 | darkmagenta | 100 | 3.9e-04 | 1.000 | 7 | GO:0048872 | BP | homeostasis of number of cells |
| 184 | darkmagenta | 100 | 6.6e-04 | 1.000 | 2 | GO:0006189 | BP | ‘de novo’ IMP biosynthetic process |
| 185 | darkmagenta | 100 | 9.2e-04 | 1.000 | 2 | GO:0045919 | BP | positive regulation of cytolysis |
| 186 | darkmagenta | 100 | 2.0e-03 | 1.000 | 2 | GO:0006188 | BP | IMP biosynthetic process |
| 187 | darkmagenta | 100 | 2.0e-03 | 1.000 | 2 | GO:0046040 | BP | IMP metabolic process |
| 188 | darkmagenta | 100 | 2.0e-03 | 1.000 | 2 | GO:1904262 | BP | negative regulation of TORC1 signaling |
| 189 | darkmagenta | 100 | 2.1e-03 | 1.000 | 3 | GO:0090329 | BP | regulation of DNA-dependent DNA replication |
| 190 | darkmagenta | 100 | 2.4e-03 | 1.000 | 2 | GO:0042268 | BP | regulation of cytolysis |
| 191 | darkolivegreen | 89 | 3.4e-05 | 0.600 | 2 | GO:0040031 | BP | snRNA modification |
| 192 | darkolivegreen | 89 | 3.4e-04 | 1.000 | 2 | GO:0051045 | BP | negative regulation of membrane protein ectodomain proteolysis |
| 193 | darkolivegreen | 89 | 1.2e-03 | 1.000 | 5 | GO:0051100 | BP | negative regulation of binding |
| 194 | darkolivegreen | 89 | 1.2e-03 | 1.000 | 3 | GO:0045744 | BP | negative regulation of G protein-coupled receptor signaling pathway |
| 195 | darkolivegreen | 89 | 1.3e-03 | 1.000 | 5 | GO:0006338 | BP | chromatin remodeling |
| 196 | darkolivegreen | 89 | 1.3e-03 | 1.000 | 4 | GO:0032091 | BP | negative regulation of protein binding |
| 197 | darkolivegreen | 89 | 1.4e-03 | 1.000 | 10 | GO:0006518 | BP | peptide metabolic process |
| 198 | darkolivegreen | 89 | 1.4e-03 | 1.000 | 9 | GO:0043043 | BP | peptide biosynthetic process |
| 199 | darkolivegreen | 89 | 1.6e-03 | 1.000 | 12 | GO:0043603 | BP | cellular amide metabolic process |
| 200 | darkolivegreen | 89 | 1.8e-03 | 1.000 | 3 | GO:0061014 | BP | positive regulation of mRNA catabolic process |
| 201 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0010070 | BP | zygote asymmetric cell division |
| 202 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0035042 | BP | fertilization, exchange of chromosomal proteins |
| 203 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0043128 | BP | positive regulation of 1-phosphatidylinositol 4-kinase activity |
| 204 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0045007 | BP | depurination |
| 205 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0061944 | BP | negative regulation of protein K48-linked ubiquitination |
| 206 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:1904237 | BP | positive regulation of substrate-dependent cell migration, cell attachment to substrate |
| 207 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:1905676 | BP | positive regulation of adaptive immune memory response |
| 208 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0008725 | MF | DNA-3-methyladenine glycosylase activity |
| 209 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0043916 | MF | DNA-7-methylguanine glycosylase activity |
| 210 | darkolivegreen2 | 31 | 2.1e-03 | 1.000 | 1 | GO:0052821 | MF | DNA-7-methyladenine glycosylase activity |
| 211 | darkolivegreen4 | 56 | 4.8e-05 | 0.850 | 4 | GO:0001658 | BP | branching involved in ureteric bud morphogenesis |
| 212 | darkolivegreen4 | 56 | 7.0e-05 | 1.000 | 4 | GO:0060675 | BP | ureteric bud morphogenesis |
| 213 | darkolivegreen4 | 56 | 7.1e-05 | 1.000 | 3 | GO:0060351 | BP | cartilage development involved in endochondral bone morphogenesis |
| 214 | darkolivegreen4 | 56 | 1.5e-04 | 1.000 | 4 | GO:0072028 | BP | nephron morphogenesis |
| 215 | darkolivegreen4 | 56 | 1.6e-04 | 1.000 | 4 | GO:0061333 | BP | renal tubule morphogenesis |
| 216 | darkolivegreen4 | 56 | 1.9e-04 | 1.000 | 4 | GO:0001656 | BP | metanephros development |
| 217 | darkolivegreen4 | 56 | 2.2e-04 | 1.000 | 2 | GO:2000020 | BP | positive regulation of male gonad development |
| 218 | darkolivegreen4 | 56 | 2.7e-04 | 1.000 | 4 | GO:0061326 | BP | renal tubule development |
| 219 | darkolivegreen4 | 56 | 2.8e-04 | 1.000 | 3 | GO:0090184 | BP | positive regulation of kidney development |
| 220 | darkolivegreen4 | 56 | 3.1e-04 | 1.000 | 4 | GO:0060993 | BP | kidney morphogenesis |
| 221 | darkorange | 118 | 1.4e-05 | 0.240 | 4 | GO:0005160 | MF | transforming growth factor beta receptor binding |
| 222 | darkorange | 118 | 4.0e-05 | 0.710 | 3 | GO:0034713 | MF | type I transforming growth factor beta receptor binding |
| 223 | darkorange | 118 | 3.4e-04 | 1.000 | 4 | GO:0060389 | BP | pathway-restricted SMAD protein phosphorylation |
| 224 | darkorange | 118 | 3.8e-04 | 1.000 | 2 | GO:0089709 | BP | L-histidine transmembrane transport |
| 225 | darkorange | 118 | 6.2e-04 | 1.000 | 2 | GO:1905007 | BP | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| 226 | darkorange | 118 | 6.8e-04 | 1.000 | 3 | GO:0070723 | BP | response to cholesterol |
| 227 | darkorange | 118 | 9.0e-04 | 1.000 | 4 | GO:0030512 | BP | negative regulation of transforming growth factor beta receptor signaling pathway |
| 228 | darkorange | 118 | 9.3e-04 | 1.000 | 2 | GO:0005024 | MF | transforming growth factor beta-activated receptor activity |
| 229 | darkorange | 118 | 1.0e-03 | 1.000 | 4 | GO:1903845 | BP | negative regulation of cellular response to transforming growth factor beta stimulus |
| 230 | darkorange | 118 | 1.1e-03 | 1.000 | 3 | GO:0060590 | MF | ATPase regulator activity |
| 231 | darkorange2 | 86 | 8.7e-04 | 1.000 | 3 | GO:0031076 | BP | embryonic camera-type eye development |
| 232 | darkorange2 | 86 | 1.2e-03 | 1.000 | 2 | GO:0072531 | BP | pyrimidine-containing compound transmembrane transport |
| 233 | darkorange2 | 86 | 2.0e-03 | 1.000 | 4 | GO:0035725 | BP | sodium ion transmembrane transport |
| 234 | darkorange2 | 86 | 3.9e-03 | 1.000 | 2 | GO:0019430 | BP | removal of superoxide radicals |
| 235 | darkorange2 | 86 | 4.4e-03 | 1.000 | 2 | GO:0071451 | BP | cellular response to superoxide |
| 236 | darkorange2 | 86 | 5.5e-03 | 1.000 | 2 | GO:0000303 | BP | response to superoxide |
| 237 | darkorange2 | 86 | 5.8e-03 | 1.000 | 5 | GO:0016791 | MF | phosphatase activity |
| 238 | darkorange2 | 86 | 5.9e-03 | 1.000 | 1 | GO:0002149 | BP | hypochlorous acid biosynthetic process |
| 239 | darkorange2 | 86 | 5.9e-03 | 1.000 | 1 | GO:0038041 | BP | cross-receptor inhibition within G protein-coupled receptor heterodimer |
| 240 | darkorange2 | 86 | 5.9e-03 | 1.000 | 1 | GO:0051838 | BP | cytolysis by host of symbiont cells |
| 241 | darkred | 157 | 1.1e-04 | 1.000 | 4 | GO:1904315 | MF | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
| 242 | darkred | 157 | 1.7e-04 | 1.000 | 4 | GO:0099529 | MF | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential |
| 243 | darkred | 157 | 2.7e-04 | 1.000 | 3 | GO:0080009 | BP | mRNA methylation |
| 244 | darkred | 157 | 6.3e-04 | 1.000 | 3 | GO:0016556 | BP | mRNA modification |
| 245 | darkred | 157 | 9.2e-04 | 1.000 | 4 | GO:0022824 | MF | transmitter-gated ion channel activity |
| 246 | darkred | 157 | 1.5e-03 | 1.000 | 4 | GO:0005230 | MF | extracellular ligand-gated ion channel activity |
| 247 | darkred | 157 | 2.1e-03 | 1.000 | 2 | GO:0072674 | BP | multinuclear osteoclast differentiation |
| 248 | darkred | 157 | 2.1e-03 | 1.000 | 2 | GO:0120013 | MF | intermembrane lipid transfer activity |
| 249 | darkred | 157 | 2.5e-03 | 1.000 | 4 | GO:1902476 | BP | chloride transmembrane transport |
| 250 | darkred | 157 | 2.7e-03 | 1.000 | 5 | GO:0060078 | BP | regulation of postsynaptic membrane potential |
| 251 | darkseagreen3 | 47 | 5.5e-05 | 0.960 | 2 | GO:0045356 | BP | positive regulation of interferon-alpha biosynthetic process |
| 252 | darkseagreen3 | 47 | 1.4e-04 | 1.000 | 2 | GO:0045359 | BP | positive regulation of interferon-beta biosynthetic process |
| 253 | darkseagreen3 | 47 | 1.8e-04 | 1.000 | 3 | GO:0001774 | BP | microglial cell activation |
| 254 | darkseagreen3 | 47 | 1.9e-04 | 1.000 | 2 | GO:0035696 | BP | monocyte extravasation |
| 255 | darkseagreen3 | 47 | 1.9e-04 | 1.000 | 2 | GO:0045416 | BP | positive regulation of interleukin-8 biosynthetic process |
| 256 | darkseagreen3 | 47 | 2.5e-04 | 1.000 | 2 | GO:0045351 | BP | type I interferon biosynthetic process |
| 257 | darkseagreen3 | 47 | 3.2e-04 | 1.000 | 2 | GO:0036020 | CC | endolysosome membrane |
| 258 | darkseagreen3 | 47 | 4.0e-04 | 1.000 | 2 | GO:0045078 | BP | positive regulation of interferon-gamma biosynthetic process |
| 259 | darkseagreen3 | 47 | 4.0e-04 | 1.000 | 2 | GO:0045414 | BP | regulation of interleukin-8 biosynthetic process |
| 260 | darkseagreen3 | 47 | 4.9e-04 | 1.000 | 2 | GO:0042228 | BP | interleukin-8 biosynthetic process |
| 261 | darkseagreen4 | 62 | 2.1e-04 | 1.000 | 16 | GO:0042995 | CC | cell projection |
| 262 | darkseagreen4 | 62 | 4.8e-04 | 1.000 | 15 | GO:0120025 | CC | plasma membrane bounded cell projection |
| 263 | darkseagreen4 | 62 | 5.4e-04 | 1.000 | 2 | GO:0072393 | BP | microtubule anchoring at microtubule organizing center |
| 264 | darkseagreen4 | 62 | 8.3e-04 | 1.000 | 2 | GO:1902018 | BP | negative regulation of cilium assembly |
| 265 | darkseagreen4 | 62 | 9.9e-04 | 1.000 | 2 | GO:0055075 | BP | potassium ion homeostasis |
| 266 | darkseagreen4 | 62 | 1.7e-03 | 1.000 | 7 | GO:0005929 | CC | cilium |
| 267 | darkseagreen4 | 62 | 1.8e-03 | 1.000 | 8 | GO:0005815 | CC | microtubule organizing center |
| 268 | darkseagreen4 | 62 | 2.5e-03 | 1.000 | 2 | GO:0048668 | BP | collateral sprouting |
| 269 | darkseagreen4 | 62 | 2.8e-03 | 1.000 | 2 | GO:0034453 | BP | microtubule anchoring |
| 270 | darkseagreen4 | 62 | 2.8e-03 | 1.000 | 2 | GO:0051642 | BP | centrosome localization |
| 271 | darkslateblue | 81 | 4.7e-04 | 1.000 | 3 | GO:0045070 | BP | positive regulation of viral genome replication |
| 272 | darkslateblue | 81 | 1.3e-03 | 1.000 | 3 | GO:0031663 | BP | lipopolysaccharide-mediated signaling pathway |
| 273 | darkslateblue | 81 | 1.5e-03 | 1.000 | 2 | GO:0007494 | BP | midgut development |
| 274 | darkslateblue | 81 | 1.5e-03 | 1.000 | 2 | GO:0042976 | BP | activation of Janus kinase activity |
| 275 | darkslateblue | 81 | 1.9e-03 | 1.000 | 3 | GO:1903902 | BP | positive regulation of viral life cycle |
| 276 | darkslateblue | 81 | 2.4e-03 | 1.000 | 2 | GO:0002544 | BP | chronic inflammatory response |
| 277 | darkslateblue | 81 | 2.5e-03 | 1.000 | 4 | GO:0044344 | BP | cellular response to fibroblast growth factor stimulus |
| 278 | darkslateblue | 81 | 2.9e-03 | 1.000 | 4 | GO:0071774 | BP | response to fibroblast growth factor |
| 279 | darkslateblue | 81 | 3.1e-03 | 1.000 | 2 | GO:0031664 | BP | regulation of lipopolysaccharide-mediated signaling pathway |
| 280 | darkslateblue | 81 | 3.6e-03 | 1.000 | 5 | GO:0045927 | BP | positive regulation of growth |
| 281 | darkturquoise | 116 | 1.2e-03 | 1.000 | 6 | GO:0030178 | BP | negative regulation of Wnt signaling pathway |
| 282 | darkturquoise | 116 | 3.2e-03 | 1.000 | 5 | GO:0090090 | BP | negative regulation of canonical Wnt signaling pathway |
| 283 | darkturquoise | 116 | 3.6e-03 | 1.000 | 2 | GO:2001044 | BP | regulation of integrin-mediated signaling pathway |
| 284 | darkturquoise | 116 | 4.5e-03 | 1.000 | 7 | GO:0002429 | BP | immune response-activating cell surface receptor signaling pathway |
| 285 | darkturquoise | 116 | 5.0e-03 | 1.000 | 7 | GO:0030111 | BP | regulation of Wnt signaling pathway |
| 286 | darkturquoise | 116 | 5.0e-03 | 1.000 | 5 | GO:0051216 | BP | cartilage development |
| 287 | darkturquoise | 116 | 5.2e-03 | 1.000 | 4 | GO:0002223 | BP | stimulatory C-type lectin receptor signaling pathway |
| 288 | darkturquoise | 116 | 5.2e-03 | 1.000 | 6 | GO:0060828 | BP | regulation of canonical Wnt signaling pathway |
| 289 | darkturquoise | 116 | 5.8e-03 | 1.000 | 4 | GO:0002220 | BP | innate immune response activating cell surface receptor signaling pathway |
| 290 | darkturquoise | 116 | 7.6e-03 | 1.000 | 1 | GO:0003374 | BP | dynamin family protein polymerization involved in mitochondrial fission |
| 291 | darkviolet | 59 | 3.2e-04 | 1.000 | 2 | GO:0035726 | BP | common myeloid progenitor cell proliferation |
| 292 | darkviolet | 59 | 9.9e-04 | 1.000 | 2 | GO:0045820 | BP | negative regulation of glycolytic process |
| 293 | darkviolet | 59 | 1.1e-03 | 1.000 | 5 | GO:0048872 | BP | homeostasis of number of cells |
| 294 | darkviolet | 59 | 1.5e-03 | 1.000 | 4 | GO:0002262 | BP | myeloid cell homeostasis |
| 295 | darkviolet | 59 | 1.6e-03 | 1.000 | 2 | GO:2001170 | BP | negative regulation of ATP biosynthetic process |
| 296 | darkviolet | 59 | 2.5e-03 | 1.000 | 2 | GO:0010667 | BP | negative regulation of cardiac muscle cell apoptotic process |
| 297 | darkviolet | 59 | 3.4e-03 | 1.000 | 2 | GO:0010664 | BP | negative regulation of striated muscle cell apoptotic process |
| 298 | darkviolet | 59 | 4.0e-03 | 1.000 | 1 | GO:0030382 | BP | sperm mitochondrion organization |
| 299 | darkviolet | 59 | 4.0e-03 | 1.000 | 1 | GO:0031959 | BP | mineralocorticoid receptor signaling pathway |
| 300 | darkviolet | 59 | 4.0e-03 | 1.000 | 1 | GO:0033030 | BP | negative regulation of neutrophil apoptotic process |
| 301 | deeppink | 29 | 5.1e-05 | 0.890 | 2 | GO:0030061 | CC | mitochondrial crista |
| 302 | deeppink | 29 | 1.6e-03 | 1.000 | 5 | GO:0007268 | BP | chemical synaptic transmission |
| 303 | deeppink | 29 | 1.8e-03 | 1.000 | 2 | GO:0007622 | BP | rhythmic behavior |
| 304 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0006062 | BP | sorbitol catabolic process |
| 305 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0017143 | BP | insecticide metabolic process |
| 306 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0018963 | BP | phthalate metabolic process |
| 307 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0021660 | BP | rhombomere 3 formation |
| 308 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0021666 | BP | rhombomere 5 formation |
| 309 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0045556 | BP | positive regulation of TRAIL biosynthetic process |
| 310 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0051160 | BP | L-xylitol catabolic process |
| 311 | firebrick3 | 35 | 4.1e-04 | 1.000 | 4 | GO:0046496 | BP | nicotinamide nucleotide metabolic process |
| 312 | firebrick3 | 35 | 8.6e-04 | 1.000 | 2 | GO:0019200 | MF | carbohydrate kinase activity |
| 313 | firebrick3 | 35 | 1.0e-03 | 1.000 | 6 | GO:0051301 | BP | cell division |
| 314 | firebrick3 | 35 | 1.9e-03 | 1.000 | 2 | GO:0001941 | BP | postsynaptic membrane organization |
| 315 | firebrick3 | 35 | 1.9e-03 | 1.000 | 2 | GO:0006739 | BP | NADP metabolic process |
| 316 | firebrick3 | 35 | 1.9e-03 | 1.000 | 2 | GO:0009954 | BP | proximal/distal pattern formation |
| 317 | firebrick3 | 35 | 2.4e-03 | 1.000 | 1 | GO:0015881 | BP | creatine transmembrane transport |
| 318 | firebrick3 | 35 | 2.4e-03 | 1.000 | 1 | GO:0072168 | BP | specification of anterior mesonephric tubule identity |
| 319 | firebrick3 | 35 | 2.4e-03 | 1.000 | 1 | GO:0072169 | BP | specification of posterior mesonephric tubule identity |
| 320 | firebrick3 | 35 | 2.4e-03 | 1.000 | 1 | GO:0072184 | BP | renal vesicle progenitor cell differentiation |
| 321 | firebrick4 | 61 | 2.4e-03 | 1.000 | 2 | GO:0000178 | CC | exosome (RNase complex) |
| 322 | firebrick4 | 61 | 3.9e-03 | 1.000 | 1 | GO:0006425 | BP | glutaminyl-tRNA aminoacylation |
| 323 | firebrick4 | 61 | 3.9e-03 | 1.000 | 1 | GO:0005945 | CC | 6-phosphofructokinase complex |
| 324 | firebrick4 | 61 | 3.9e-03 | 1.000 | 1 | GO:1902773 | CC | GTPase activator complex |
| 325 | firebrick4 | 61 | 3.9e-03 | 1.000 | 1 | GO:0004819 | MF | glutamine-tRNA ligase activity |
| 326 | firebrick4 | 61 | 3.9e-03 | 1.000 | 1 | GO:0005166 | MF | neurotrophin p75 receptor binding |
| 327 | firebrick4 | 61 | 3.9e-03 | 1.000 | 1 | GO:0008554 | MF | sodium-exporting ATPase activity, phosphorylative mechanism |
| 328 | firebrick4 | 61 | 4.4e-03 | 1.000 | 4 | GO:0050807 | BP | regulation of synapse organization |
| 329 | firebrick4 | 61 | 4.7e-03 | 1.000 | 3 | GO:0032273 | BP | positive regulation of protein polymerization |
| 330 | firebrick4 | 61 | 4.7e-03 | 1.000 | 4 | GO:0050803 | BP | regulation of synapse structure or activity |
| 331 | floralwhite | 87 | 3.2e-04 | 1.000 | 2 | GO:0030174 | BP | regulation of DNA-dependent DNA replication initiation |
| 332 | floralwhite | 87 | 7.8e-04 | 1.000 | 3 | GO:0006084 | BP | acetyl-CoA metabolic process |
| 333 | floralwhite | 87 | 1.4e-03 | 1.000 | 2 | GO:0050884 | BP | neuromuscular process controlling posture |
| 334 | floralwhite | 87 | 1.4e-03 | 1.000 | 2 | GO:0060123 | BP | regulation of growth hormone secretion |
| 335 | floralwhite | 87 | 1.7e-03 | 1.000 | 2 | GO:0006089 | BP | lactate metabolic process |
| 336 | floralwhite | 87 | 2.0e-03 | 1.000 | 3 | GO:0061844 | BP | antimicrobial humoral immune response mediated by antimicrobial peptide |
| 337 | floralwhite | 87 | 2.0e-03 | 1.000 | 2 | GO:0005095 | MF | GTPase inhibitor activity |
| 338 | floralwhite | 87 | 2.4e-03 | 1.000 | 2 | GO:0030252 | BP | growth hormone secretion |
| 339 | floralwhite | 87 | 3.2e-03 | 1.000 | 2 | GO:0071682 | CC | endocytic vesicle lumen |
| 340 | floralwhite | 87 | 3.7e-03 | 1.000 | 2 | GO:0006086 | BP | acetyl-CoA biosynthetic process from pyruvate |
| 341 | green | 680 | 9.8e-05 | 1.000 | 5 | GO:1903818 | BP | positive regulation of voltage-gated potassium channel activity |
| 342 | green | 680 | 3.2e-04 | 1.000 | 3 | GO:0070816 | BP | phosphorylation of RNA polymerase II C-terminal domain |
| 343 | green | 680 | 3.2e-04 | 1.000 | 3 | GO:0071673 | BP | positive regulation of smooth muscle cell chemotaxis |
| 344 | green | 680 | 6.0e-04 | 1.000 | 6 | GO:0010996 | BP | response to auditory stimulus |
| 345 | green | 680 | 6.4e-04 | 1.000 | 50 | GO:0008284 | BP | positive regulation of cell proliferation |
| 346 | green | 680 | 7.8e-04 | 1.000 | 3 | GO:0052629 | MF | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity |
| 347 | green | 680 | 9.0e-04 | 1.000 | 26 | GO:0050673 | BP | epithelial cell proliferation |
| 348 | green | 680 | 9.3e-04 | 1.000 | 6 | GO:0000307 | CC | cyclin-dependent protein kinase holoenzyme complex |
| 349 | green | 680 | 1.0e-03 | 1.000 | 9 | GO:0006855 | BP | drug transmembrane transport |
| 350 | green | 680 | 1.1e-03 | 1.000 | 23 | GO:0050678 | BP | regulation of epithelial cell proliferation |
| 351 | greenyellow | 264 | 3.0e-04 | 1.000 | 2 | GO:0006660 | BP | phosphatidylserine catabolic process |
| 352 | greenyellow | 264 | 8.1e-04 | 1.000 | 8 | GO:0016571 | BP | histone methylation |
| 353 | greenyellow | 264 | 9.0e-04 | 1.000 | 2 | GO:0090116 | BP | C-5 methylation of cytosine |
| 354 | greenyellow | 264 | 9.0e-04 | 1.000 | 2 | GO:0003886 | MF | DNA (cytosine-5-)-methyltransferase activity |
| 355 | greenyellow | 264 | 1.1e-03 | 1.000 | 6 | GO:0007189 | BP | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| 356 | greenyellow | 264 | 1.2e-03 | 1.000 | 10 | GO:0042113 | BP | B cell activation |
| 357 | greenyellow | 264 | 1.3e-03 | 1.000 | 3 | GO:0045722 | BP | positive regulation of gluconeogenesis |
| 358 | greenyellow | 264 | 1.4e-03 | 1.000 | 7 | GO:0034968 | BP | histone lysine methylation |
| 359 | greenyellow | 264 | 1.8e-03 | 1.000 | 2 | GO:0032776 | BP | DNA methylation on cytosine |
| 360 | greenyellow | 264 | 1.8e-03 | 1.000 | 2 | GO:0035948 | BP | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter |
| 361 | grey | 372 | 5.8e-04 | 1.000 | 2 | GO:0099642 | BP | retrograde axonal protein transport |
| 362 | grey | 372 | 5.8e-04 | 1.000 | 2 | GO:0005223 | MF | intracellular cGMP-activated cation channel activity |
| 363 | grey | 372 | 7.1e-04 | 1.000 | 3 | GO:0030259 | BP | lipid glycosylation |
| 364 | grey | 372 | 1.7e-03 | 1.000 | 2 | GO:0030185 | BP | nitric oxide transport |
| 365 | grey | 372 | 1.7e-03 | 1.000 | 2 | GO:0035063 | BP | nuclear speck organization |
| 366 | grey | 372 | 1.7e-03 | 1.000 | 2 | GO:0048619 | BP | embryonic hindgut morphogenesis |
| 367 | grey | 372 | 1.7e-03 | 1.000 | 2 | GO:1903070 | BP | negative regulation of ER-associated ubiquitin-dependent protein catabolic process |
| 368 | grey | 372 | 1.7e-03 | 1.000 | 2 | GO:0002079 | CC | inner acrosomal membrane |
| 369 | grey | 372 | 1.7e-03 | 1.000 | 2 | GO:0008109 | MF | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity |
| 370 | grey | 372 | 1.9e-03 | 1.000 | 12 | GO:0007018 | BP | microtubule-based movement |
| 371 | grey60 | 197 | 6.2e-04 | 1.000 | 7 | GO:0030856 | BP | regulation of epithelial cell differentiation |
| 372 | grey60 | 197 | 1.6e-03 | 1.000 | 2 | GO:0004030 | MF | aldehyde dehydrogenase [NAD(P)+] activity |
| 373 | grey60 | 197 | 2.1e-03 | 1.000 | 3 | GO:0031440 | BP | regulation of mRNA 3’-end processing |
| 374 | grey60 | 197 | 2.2e-03 | 1.000 | 4 | GO:0098900 | BP | regulation of action potential |
| 375 | grey60 | 197 | 3.2e-03 | 1.000 | 6 | GO:0055001 | BP | muscle cell development |
| 376 | grey60 | 197 | 3.3e-03 | 1.000 | 2 | GO:0090160 | BP | Golgi to lysosome transport |
| 377 | grey60 | 197 | 3.3e-03 | 1.000 | 2 | GO:0098789 | BP | pre-mRNA cleavage required for polyadenylation |
| 378 | grey60 | 197 | 3.3e-03 | 1.000 | 2 | GO:0043121 | MF | neurotrophin binding |
| 379 | grey60 | 197 | 3.4e-03 | 1.000 | 4 | GO:0042267 | BP | natural killer cell mediated cytotoxicity |
| 380 | grey60 | 197 | 3.5e-03 | 1.000 | 3 | GO:0098901 | BP | regulation of cardiac muscle cell action potential |
| 381 | honeydew | 44 | 3.7e-05 | 0.640 | 3 | GO:0043457 | BP | regulation of cellular respiration |
| 382 | honeydew | 44 | 7.9e-05 | 1.000 | 2 | GO:1901857 | BP | positive regulation of cellular respiration |
| 383 | honeydew | 44 | 1.0e-04 | 1.000 | 7 | GO:0006091 | BP | generation of precursor metabolites and energy |
| 384 | honeydew | 44 | 1.4e-04 | 1.000 | 4 | GO:1903578 | BP | regulation of ATP metabolic process |
| 385 | honeydew | 44 | 3.1e-04 | 1.000 | 5 | GO:0046034 | BP | ATP metabolic process |
| 386 | honeydew | 44 | 3.3e-04 | 1.000 | 4 | GO:0043467 | BP | regulation of generation of precursor metabolites and energy |
| 387 | honeydew | 44 | 5.0e-04 | 1.000 | 4 | GO:0009168 | BP | purine ribonucleoside monophosphate biosynthetic process |
| 388 | honeydew | 44 | 6.1e-04 | 1.000 | 2 | GO:0071871 | BP | response to epinephrine |
| 389 | honeydew | 44 | 6.2e-04 | 1.000 | 3 | GO:0005746 | CC | mitochondrial respiratory chain |
| 390 | honeydew | 44 | 6.4e-04 | 1.000 | 4 | GO:0022900 | BP | electron transport chain |
| 391 | honeydew1 | 71 | 2.1e-04 | 1.000 | 2 | GO:0004706 | MF | JUN kinase kinase kinase activity |
| 392 | honeydew1 | 71 | 9.1e-04 | 1.000 | 2 | GO:0007256 | BP | activation of JNKK activity |
| 393 | honeydew1 | 71 | 1.0e-03 | 1.000 | 3 | GO:0000186 | BP | activation of MAPKK activity |
| 394 | honeydew1 | 71 | 1.1e-03 | 1.000 | 52 | GO:0005737 | CC | cytoplasm |
| 395 | honeydew1 | 71 | 1.9e-03 | 1.000 | 3 | GO:0031594 | CC | neuromuscular junction |
| 396 | honeydew1 | 71 | 2.0e-03 | 1.000 | 4 | GO:0016874 | MF | ligase activity |
| 397 | honeydew1 | 71 | 2.1e-03 | 1.000 | 2 | GO:0016010 | CC | dystrophin-associated glycoprotein complex |
| 398 | honeydew1 | 71 | 2.4e-03 | 1.000 | 2 | GO:0045663 | BP | positive regulation of myoblast differentiation |
| 399 | honeydew1 | 71 | 2.7e-03 | 1.000 | 2 | GO:0004709 | MF | MAP kinase kinase kinase activity |
| 400 | honeydew1 | 71 | 4.6e-03 | 1.000 | 1 | GO:0001949 | BP | sebaceous gland cell differentiation |
| 401 | indianred3 | 36 | 3.3e-04 | 1.000 | 2 | GO:2000251 | BP | positive regulation of actin cytoskeleton reorganization |
| 402 | indianred3 | 36 | 9.4e-04 | 1.000 | 2 | GO:0009083 | BP | branched-chain amino acid catabolic process |
| 403 | indianred3 | 36 | 1.0e-03 | 1.000 | 5 | GO:0051090 | BP | regulation of DNA-binding transcription factor activity |
| 404 | indianred3 | 36 | 1.4e-03 | 1.000 | 4 | GO:0051091 | BP | positive regulation of DNA-binding transcription factor activity |
| 405 | indianred3 | 36 | 1.7e-03 | 1.000 | 2 | GO:2000249 | BP | regulation of actin cytoskeleton reorganization |
| 406 | indianred3 | 36 | 2.3e-03 | 1.000 | 1 | GO:1904140 | BP | negative regulation of microglial cell migration |
| 407 | indianred3 | 36 | 2.3e-03 | 1.000 | 1 | GO:1990145 | BP | maintenance of translational fidelity |
| 408 | indianred3 | 36 | 2.3e-03 | 1.000 | 1 | GO:0008709 | MF | cholate 7-alpha-dehydrogenase activity |
| 409 | indianred3 | 36 | 2.3e-03 | 1.000 | 1 | GO:0030283 | MF | testosterone dehydrogenase [NAD(P)] activity |
| 410 | indianred3 | 36 | 2.3e-03 | 1.000 | 1 | GO:0047015 | MF | 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity |
| 411 | indianred4 | 58 | 2.2e-04 | 1.000 | 3 | GO:0033017 | CC | sarcoplasmic reticulum membrane |
| 412 | indianred4 | 58 | 2.8e-04 | 1.000 | 2 | GO:0033018 | CC | sarcoplasmic reticulum lumen |
| 413 | indianred4 | 58 | 4.7e-04 | 1.000 | 2 | GO:0014894 | BP | response to denervation involved in regulation of muscle adaptation |
| 414 | indianred4 | 58 | 5.9e-04 | 1.000 | 2 | GO:0014870 | BP | response to muscle inactivity |
| 415 | indianred4 | 58 | 5.9e-04 | 1.000 | 2 | GO:2001256 | BP | regulation of store-operated calcium entry |
| 416 | indianred4 | 58 | 8.6e-04 | 1.000 | 2 | GO:0014854 | BP | response to inactivity |
| 417 | indianred4 | 58 | 8.6e-04 | 1.000 | 2 | GO:0042308 | BP | negative regulation of protein import into nucleus |
| 418 | indianred4 | 58 | 9.2e-04 | 1.000 | 4 | GO:0017038 | BP | protein import |
| 419 | indianred4 | 58 | 1.0e-03 | 1.000 | 2 | GO:0002115 | BP | store-operated calcium entry |
| 420 | indianred4 | 58 | 1.0e-03 | 1.000 | 3 | GO:0016529 | CC | sarcoplasmic reticulum |
| 421 | ivory | 92 | 1.5e-03 | 1.000 | 2 | GO:0005871 | CC | kinesin complex |
| 422 | ivory | 92 | 2.7e-03 | 1.000 | 3 | GO:0005782 | CC | peroxisomal matrix |
| 423 | ivory | 92 | 2.7e-03 | 1.000 | 3 | GO:0016655 | MF | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
| 424 | ivory | 92 | 3.4e-03 | 1.000 | 3 | GO:0006400 | BP | tRNA modification |
| 425 | ivory | 92 | 3.4e-03 | 1.000 | 2 | GO:0071379 | BP | cellular response to prostaglandin stimulus |
| 426 | ivory | 92 | 3.9e-03 | 1.000 | 2 | GO:0017025 | MF | TBP-class protein binding |
| 427 | ivory | 92 | 5.9e-03 | 1.000 | 1 | GO:0002128 | BP | tRNA nucleoside ribose methylation |
| 428 | ivory | 92 | 5.9e-03 | 1.000 | 1 | GO:0021852 | BP | pyramidal neuron migration |
| 429 | ivory | 92 | 5.9e-03 | 1.000 | 1 | GO:0034769 | BP | basement membrane disassembly |
| 430 | ivory | 92 | 5.9e-03 | 1.000 | 1 | GO:0035732 | BP | nitric oxide storage |
| 431 | lavenderblush2 | 48 | 1.9e-03 | 1.000 | 2 | GO:0006706 | BP | steroid catabolic process |
| 432 | lavenderblush2 | 48 | 2.3e-03 | 1.000 | 2 | GO:2000171 | BP | negative regulation of dendrite development |
| 433 | lavenderblush2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0006711 | BP | estrogen catabolic process |
| 434 | lavenderblush2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0015821 | BP | methionine transport |
| 435 | lavenderblush2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0019546 | BP | arginine deiminase pathway |
| 436 | lavenderblush2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0031161 | BP | phosphatidylinositol catabolic process |
| 437 | lavenderblush2 | 48 | 3.3e-03 | 1.000 | 1 | GO:1900075 | BP | positive regulation of neuromuscular synaptic transmission |
| 438 | lavenderblush2 | 48 | 3.3e-03 | 1.000 | 1 | GO:1904800 | BP | negative regulation of neuron remodeling |
| 439 | lavenderblush2 | 48 | 3.3e-03 | 1.000 | 1 | GO:2000173 | BP | negative regulation of branching morphogenesis of a nerve |
| 440 | lavenderblush2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0004304 | MF | estrone sulfotransferase activity |
| 441 | lavenderblush3 | 69 | 7.4e-04 | 1.000 | 3 | GO:0050885 | BP | neuromuscular process controlling balance |
| 442 | lavenderblush3 | 69 | 1.5e-03 | 1.000 | 2 | GO:0001972 | MF | retinoic acid binding |
| 443 | lavenderblush3 | 69 | 2.8e-03 | 1.000 | 2 | GO:0006488 | BP | dolichol-linked oligosaccharide biosynthetic process |
| 444 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0002302 | BP | CD8-positive, alpha-beta T cell differentiation involved in immune response |
| 445 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0018272 | BP | protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine |
| 446 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0018276 | BP | isopeptide cross-linking via N6-glycyl-L-lysine |
| 447 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0035752 | BP | lysosomal lumen pH elevation |
| 448 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0044524 | BP | protein sulfhydration |
| 449 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0072229 | BP | metanephric proximal convoluted tubule development |
| 450 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:1902860 | BP | propionyl-CoA biosynthetic process |
| 451 | lightblue4 | 35 | 2.2e-03 | 1.000 | 1 | GO:0009104 | BP | lipopolysaccharide catabolic process |
| 452 | lightblue4 | 35 | 2.2e-03 | 1.000 | 1 | GO:0035494 | BP | SNARE complex disassembly |
| 453 | lightblue4 | 35 | 2.2e-03 | 1.000 | 1 | GO:0018773 | MF | acetylpyruvate hydrolase activity |
| 454 | lightblue4 | 35 | 2.2e-03 | 1.000 | 1 | GO:0034545 | MF | fumarylpyruvate hydrolase activity |
| 455 | lightblue4 | 35 | 2.2e-03 | 1.000 | 1 | GO:0047621 | MF | acylpyruvate hydrolase activity |
| 456 | lightblue4 | 35 | 2.2e-03 | 1.000 | 1 | GO:0050528 | MF | acyloxyacyl hydrolase activity |
| 457 | lightblue4 | 35 | 2.7e-03 | 1.000 | 2 | GO:0035254 | MF | glutamate receptor binding |
| 458 | lightblue4 | 35 | 4.2e-03 | 1.000 | 3 | GO:0006888 | BP | ER to Golgi vesicle-mediated transport |
| 459 | lightblue4 | 35 | 4.4e-03 | 1.000 | 1 | GO:0034125 | BP | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
| 460 | lightblue4 | 35 | 4.4e-03 | 1.000 | 1 | GO:0035772 | BP | interleukin-13-mediated signaling pathway |
| 461 | lightcoral | 60 | 3.1e-04 | 1.000 | 2 | GO:0030422 | BP | production of siRNA involved in RNA interference |
| 462 | lightcoral | 60 | 9.6e-04 | 1.000 | 2 | GO:0016246 | BP | RNA interference |
| 463 | lightcoral | 60 | 1.1e-03 | 1.000 | 2 | GO:0090399 | BP | replicative senescence |
| 464 | lightcoral | 60 | 1.5e-03 | 1.000 | 2 | GO:0000400 | MF | four-way junction DNA binding |
| 465 | lightcoral | 60 | 2.7e-03 | 1.000 | 5 | GO:0007568 | BP | aging |
| 466 | lightcoral | 60 | 3.3e-03 | 1.000 | 2 | GO:0033032 | BP | regulation of myeloid cell apoptotic process |
| 467 | lightcoral | 60 | 3.5e-03 | 1.000 | 12 | GO:0010941 | BP | regulation of cell death |
| 468 | lightcoral | 60 | 3.6e-03 | 1.000 | 2 | GO:0090344 | BP | negative regulation of cell aging |
| 469 | lightcoral | 60 | 3.9e-03 | 1.000 | 1 | GO:0001815 | BP | positive regulation of antibody-dependent cellular cytotoxicity |
| 470 | lightcoral | 60 | 3.9e-03 | 1.000 | 1 | GO:0038160 | BP | CXCL12-activated CXCR4 signaling pathway |
| 471 | lightcyan | 191 | 6.3e-04 | 1.000 | 3 | GO:0004693 | MF | cyclin-dependent protein serine/threonine kinase activity |
| 472 | lightcyan | 191 | 7.8e-04 | 1.000 | 3 | GO:0097472 | MF | cyclin-dependent protein kinase activity |
| 473 | lightcyan | 191 | 9.2e-04 | 1.000 | 2 | GO:0000056 | BP | ribosomal small subunit export from nucleus |
| 474 | lightcyan | 191 | 9.2e-04 | 1.000 | 2 | GO:0004090 | MF | carbonyl reductase (NADPH) activity |
| 475 | lightcyan | 191 | 1.5e-03 | 1.000 | 2 | GO:0060916 | BP | mesenchymal cell proliferation involved in lung development |
| 476 | lightcyan | 191 | 1.6e-03 | 1.000 | 3 | GO:0008266 | MF | poly(U) RNA binding |
| 477 | lightcyan | 191 | 2.2e-03 | 1.000 | 3 | GO:0008187 | MF | poly-pyrimidine tract binding |
| 478 | lightcyan | 191 | 2.2e-03 | 1.000 | 3 | GO:0097718 | MF | disordered domain specific binding |
| 479 | lightcyan | 191 | 2.3e-03 | 1.000 | 2 | GO:0000054 | BP | ribosomal subunit export from nucleus |
| 480 | lightcyan | 191 | 2.3e-03 | 1.000 | 2 | GO:0002177 | CC | manchette |
| 481 | lightcyan1 | 86 | 6.6e-04 | 1.000 | 2 | GO:0042415 | BP | norepinephrine metabolic process |
| 482 | lightcyan1 | 86 | 2.0e-03 | 1.000 | 2 | GO:0005242 | MF | inward rectifier potassium channel activity |
| 483 | lightcyan1 | 86 | 3.2e-03 | 1.000 | 2 | GO:0034505 | BP | tooth mineralization |
| 484 | lightcyan1 | 86 | 5.7e-03 | 1.000 | 1 | GO:0005998 | BP | xylulose catabolic process |
| 485 | lightcyan1 | 86 | 5.7e-03 | 1.000 | 1 | GO:0009751 | BP | response to salicylic acid |
| 486 | lightcyan1 | 86 | 5.7e-03 | 1.000 | 1 | GO:0010272 | BP | response to silver ion |
| 487 | lightcyan1 | 86 | 5.7e-03 | 1.000 | 1 | GO:0034342 | BP | response to type III interferon |
| 488 | lightcyan1 | 86 | 5.7e-03 | 1.000 | 1 | GO:0060127 | BP | prolactin secreting cell differentiation |
| 489 | lightcyan1 | 86 | 5.7e-03 | 1.000 | 1 | GO:0071529 | BP | cementum mineralization |
| 490 | lightcyan1 | 86 | 5.7e-03 | 1.000 | 1 | GO:0097188 | BP | dentin mineralization |
| 491 | lightgreen | 165 | 1.1e-04 | 1.000 | 2 | GO:0048611 | BP | embryonic ectodermal digestive tract development |
| 492 | lightgreen | 165 | 4.6e-04 | 1.000 | 3 | GO:0090335 | BP | regulation of brown fat cell differentiation |
| 493 | lightgreen | 165 | 6.4e-04 | 1.000 | 2 | GO:0015811 | BP | L-cystine transport |
| 494 | lightgreen | 165 | 6.4e-04 | 1.000 | 2 | GO:0015184 | MF | L-cystine transmembrane transporter activity |
| 495 | lightgreen | 165 | 9.5e-04 | 1.000 | 3 | GO:2000114 | BP | regulation of establishment of cell polarity |
| 496 | lightgreen | 165 | 1.1e-03 | 1.000 | 2 | GO:0001554 | BP | luteolysis |
| 497 | lightgreen | 165 | 1.1e-03 | 1.000 | 3 | GO:0044322 | CC | endoplasmic reticulum quality control compartment |
| 498 | lightgreen | 165 | 1.3e-03 | 1.000 | 3 | GO:0032878 | BP | regulation of establishment or maintenance of cell polarity |
| 499 | lightgreen | 165 | 1.9e-03 | 1.000 | 3 | GO:0038111 | BP | interleukin-7-mediated signaling pathway |
| 500 | lightgreen | 165 | 2.9e-03 | 1.000 | 2 | GO:0043117 | BP | positive regulation of vascular permeability |
| 501 | lightpink3 | 48 | 1.9e-04 | 1.000 | 2 | GO:0031848 | BP | protection from non-homologous end joining at telomere |
| 502 | lightpink3 | 48 | 3.2e-04 | 1.000 | 4 | GO:0051053 | BP | negative regulation of DNA metabolic process |
| 503 | lightpink3 | 48 | 3.2e-04 | 1.000 | 2 | GO:0043247 | BP | telomere maintenance in response to DNA damage |
| 504 | lightpink3 | 48 | 3.2e-04 | 1.000 | 2 | GO:1900118 | BP | negative regulation of execution phase of apoptosis |
| 505 | lightpink3 | 48 | 1.2e-03 | 1.000 | 3 | GO:0000784 | CC | nuclear chromosome, telomeric region |
| 506 | lightpink3 | 48 | 1.8e-03 | 1.000 | 2 | GO:1904357 | BP | negative regulation of telomere maintenance via telomere lengthening |
| 507 | lightpink3 | 48 | 3.1e-03 | 1.000 | 1 | GO:0002215 | BP | defense response to nematode |
| 508 | lightpink3 | 48 | 3.1e-03 | 1.000 | 1 | GO:0035713 | BP | response to nitrogen dioxide |
| 509 | lightpink3 | 48 | 3.1e-03 | 1.000 | 1 | GO:0060381 | BP | positive regulation of single-stranded telomeric DNA binding |
| 510 | lightpink3 | 48 | 3.1e-03 | 1.000 | 1 | GO:0070184 | BP | mitochondrial tyrosyl-tRNA aminoacylation |
| 511 | lightpink4 | 65 | 5.4e-04 | 1.000 | 2 | GO:0002566 | BP | somatic diversification of immune receptors via somatic mutation |
| 512 | lightpink4 | 65 | 1.9e-03 | 1.000 | 3 | GO:0046209 | BP | nitric oxide metabolic process |
| 513 | lightpink4 | 65 | 2.5e-03 | 1.000 | 2 | GO:0008053 | BP | mitochondrial fusion |
| 514 | lightpink4 | 65 | 3.3e-03 | 1.000 | 3 | GO:0006497 | BP | protein lipidation |
| 515 | lightpink4 | 65 | 3.9e-03 | 1.000 | 3 | GO:0042158 | BP | lipoprotein biosynthetic process |
| 516 | lightpink4 | 65 | 3.9e-03 | 1.000 | 2 | GO:0051560 | BP | mitochondrial calcium ion homeostasis |
| 517 | lightpink4 | 65 | 3.9e-03 | 1.000 | 2 | GO:0000993 | MF | RNA polymerase II complex binding |
| 518 | lightpink4 | 65 | 4.0e-03 | 1.000 | 3 | GO:0002027 | BP | regulation of heart rate |
| 519 | lightpink4 | 65 | 4.4e-03 | 1.000 | 1 | GO:0043602 | BP | nitrate catabolic process |
| 520 | lightpink4 | 65 | 4.4e-03 | 1.000 | 1 | GO:0046210 | BP | nitric oxide catabolic process |
| 521 | lightslateblue | 39 | 9.2e-05 | 1.000 | 7 | GO:0009306 | BP | protein secretion |
| 522 | lightslateblue | 39 | 1.4e-04 | 1.000 | 7 | GO:0002790 | BP | peptide secretion |
| 523 | lightslateblue | 39 | 6.3e-04 | 1.000 | 2 | GO:2000311 | BP | regulation of AMPA receptor activity |
| 524 | lightslateblue | 39 | 7.2e-04 | 1.000 | 4 | GO:0030073 | BP | insulin secretion |
| 525 | lightslateblue | 39 | 1.1e-03 | 1.000 | 10 | GO:0015031 | BP | protein transport |
| 526 | lightslateblue | 39 | 1.4e-03 | 1.000 | 10 | GO:0015833 | BP | peptide transport |
| 527 | lightslateblue | 39 | 1.5e-03 | 1.000 | 4 | GO:0030072 | BP | peptide hormone secretion |
| 528 | lightslateblue | 39 | 1.5e-03 | 1.000 | 10 | GO:0042886 | BP | amide transport |
| 529 | lightslateblue | 39 | 2.0e-03 | 1.000 | 10 | GO:0045184 | BP | establishment of protein localization |
| 530 | lightslateblue | 39 | 2.0e-03 | 1.000 | 5 | GO:0050708 | BP | regulation of protein secretion |
| 531 | lightsteelblue | 51 | 6.0e-05 | 1.000 | 2 | GO:2000587 | BP | negative regulation of platelet-derived growth factor receptor-beta signaling pathway |
| 532 | lightsteelblue | 51 | 2.8e-04 | 1.000 | 2 | GO:2000586 | BP | regulation of platelet-derived growth factor receptor-beta signaling pathway |
| 533 | lightsteelblue | 51 | 3.5e-04 | 1.000 | 2 | GO:0031987 | BP | locomotion involved in locomotory behavior |
| 534 | lightsteelblue | 51 | 5.4e-04 | 1.000 | 2 | GO:0010642 | BP | negative regulation of platelet-derived growth factor receptor signaling pathway |
| 535 | lightsteelblue | 51 | 7.1e-04 | 1.000 | 3 | GO:0010812 | BP | negative regulation of cell-substrate adhesion |
| 536 | lightsteelblue | 51 | 7.6e-04 | 1.000 | 2 | GO:1900221 | BP | regulation of amyloid-beta clearance |
| 537 | lightsteelblue | 51 | 8.9e-04 | 1.000 | 2 | GO:0035791 | BP | platelet-derived growth factor receptor-beta signaling pathway |
| 538 | lightsteelblue | 51 | 1.8e-03 | 1.000 | 2 | GO:0010640 | BP | regulation of platelet-derived growth factor receptor signaling pathway |
| 539 | lightsteelblue | 51 | 2.0e-03 | 1.000 | 2 | GO:0014912 | BP | negative regulation of smooth muscle cell migration |
| 540 | lightsteelblue | 51 | 3.2e-03 | 1.000 | 1 | GO:0014810 | BP | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
| 541 | lightsteelblue1 | 87 | 4.6e-04 | 1.000 | 2 | GO:0015939 | BP | pantothenate metabolic process |
| 542 | lightsteelblue1 | 87 | 8.6e-04 | 1.000 | 2 | GO:0017128 | MF | phospholipid scramblase activity |
| 543 | lightsteelblue1 | 87 | 9.9e-04 | 1.000 | 3 | GO:0097035 | BP | regulation of membrane lipid distribution |
| 544 | lightsteelblue1 | 87 | 1.1e-03 | 1.000 | 2 | GO:0017121 | BP | phospholipid scrambling |
| 545 | lightsteelblue1 | 87 | 1.5e-03 | 1.000 | 3 | GO:0005548 | MF | phospholipid transporter activity |
| 546 | lightsteelblue1 | 87 | 3.1e-03 | 1.000 | 2 | GO:0046931 | BP | pore complex assembly |
| 547 | lightsteelblue1 | 87 | 4.0e-03 | 1.000 | 2 | GO:0070102 | BP | interleukin-6-mediated signaling pathway |
| 548 | lightsteelblue1 | 87 | 5.2e-03 | 1.000 | 4 | GO:0015698 | BP | inorganic anion transport |
| 549 | lightsteelblue1 | 87 | 5.6e-03 | 1.000 | 1 | GO:0000718 | BP | nucleotide-excision repair, DNA damage removal |
| 550 | lightsteelblue1 | 87 | 5.6e-03 | 1.000 | 1 | GO:0005999 | BP | xylulose biosynthetic process |
| 551 | lightyellow | 141 | 1.1e-03 | 1.000 | 5 | GO:0043666 | BP | regulation of phosphoprotein phosphatase activity |
| 552 | lightyellow | 141 | 1.2e-03 | 1.000 | 2 | GO:0036089 | BP | cleavage furrow formation |
| 553 | lightyellow | 141 | 1.2e-03 | 1.000 | 2 | GO:0070562 | BP | regulation of vitamin D receptor signaling pathway |
| 554 | lightyellow | 141 | 1.7e-03 | 1.000 | 2 | GO:0046920 | MF | alpha-(1->3)-fucosyltransferase activity |
| 555 | lightyellow | 141 | 2.3e-03 | 1.000 | 2 | GO:2000035 | BP | regulation of stem cell division |
| 556 | lightyellow | 141 | 2.4e-03 | 1.000 | 9 | GO:0045177 | CC | apical part of cell |
| 557 | lightyellow | 141 | 2.7e-03 | 1.000 | 5 | GO:0035304 | BP | regulation of protein dephosphorylation |
| 558 | lightyellow | 141 | 2.9e-03 | 1.000 | 2 | GO:0070561 | BP | vitamin D receptor signaling pathway |
| 559 | lightyellow | 141 | 3.6e-03 | 1.000 | 2 | GO:0008655 | BP | pyrimidine-containing compound salvage |
| 560 | lightyellow | 141 | 3.6e-03 | 1.000 | 2 | GO:0043097 | BP | pyrimidine nucleoside salvage |
| 561 | magenta | 279 | 2.9e-05 | 0.510 | 13 | GO:0034504 | BP | protein localization to nucleus |
| 562 | magenta | 279 | 4.4e-04 | 1.000 | 8 | GO:0019218 | BP | regulation of steroid metabolic process |
| 563 | magenta | 279 | 4.6e-04 | 1.000 | 3 | GO:0021892 | BP | cerebral cortex GABAergic interneuron differentiation |
| 564 | magenta | 279 | 8.8e-04 | 1.000 | 3 | GO:0097154 | BP | GABAergic neuron differentiation |
| 565 | magenta | 279 | 9.8e-04 | 1.000 | 2 | GO:0004449 | MF | isocitrate dehydrogenase (NAD+) activity |
| 566 | magenta | 279 | 1.1e-03 | 1.000 | 8 | GO:1905952 | BP | regulation of lipid localization |
| 567 | magenta | 279 | 1.3e-03 | 1.000 | 14 | GO:0010876 | BP | lipid localization |
| 568 | magenta | 279 | 1.3e-03 | 1.000 | 13 | GO:0008202 | BP | steroid metabolic process |
| 569 | magenta | 279 | 1.9e-03 | 1.000 | 3 | GO:0000339 | MF | RNA cap binding |
| 570 | magenta | 279 | 2.3e-03 | 1.000 | 7 | GO:0030176 | CC | integral component of endoplasmic reticulum membrane |
| 571 | magenta4 | 43 | 2.9e-03 | 1.000 | 1 | GO:0072715 | BP | cellular response to selenite ion |
| 572 | magenta4 | 43 | 2.9e-03 | 1.000 | 1 | GO:0097380 | BP | dorsal spinal cord interneuron anterior axon guidance |
| 573 | magenta4 | 43 | 2.9e-03 | 1.000 | 1 | GO:1904570 | BP | negative regulation of selenocysteine incorporation |
| 574 | magenta4 | 43 | 2.9e-03 | 1.000 | 1 | GO:1904574 | BP | negative regulation of selenocysteine insertion sequence binding |
| 575 | magenta4 | 43 | 2.9e-03 | 1.000 | 1 | GO:0005148 | MF | prolactin receptor binding |
| 576 | magenta4 | 43 | 2.9e-03 | 1.000 | 1 | GO:0072555 | MF | 17-beta-ketosteroid reductase activity |
| 577 | magenta4 | 43 | 2.9e-03 | 1.000 | 1 | GO:0072582 | MF | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity |
| 578 | magenta4 | 43 | 5.8e-03 | 1.000 | 1 | GO:0002268 | BP | follicular dendritic cell differentiation |
| 579 | magenta4 | 43 | 5.8e-03 | 1.000 | 1 | GO:0018008 | BP | N-terminal peptidyl-glycine N-myristoylation |
| 580 | magenta4 | 43 | 5.8e-03 | 1.000 | 1 | GO:0021934 | BP | hindbrain tangential cell migration |
| 581 | maroon | 76 | 4.0e-04 | 1.000 | 2 | GO:0019855 | MF | calcium channel inhibitor activity |
| 582 | maroon | 76 | 9.4e-04 | 1.000 | 2 | GO:0005385 | MF | zinc ion transmembrane transporter activity |
| 583 | maroon | 76 | 1.2e-03 | 1.000 | 4 | GO:0051282 | BP | regulation of sequestering of calcium ion |
| 584 | maroon | 76 | 1.3e-03 | 1.000 | 4 | GO:0051208 | BP | sequestering of calcium ion |
| 585 | maroon | 76 | 2.0e-03 | 1.000 | 2 | GO:0015278 | MF | calcium-release channel activity |
| 586 | maroon | 76 | 2.0e-03 | 1.000 | 2 | GO:0072509 | MF | divalent inorganic cation transmembrane transporter activity |
| 587 | maroon | 76 | 2.8e-03 | 1.000 | 3 | GO:0030512 | BP | negative regulation of transforming growth factor beta receptor signaling pathway |
| 588 | maroon | 76 | 3.1e-03 | 1.000 | 2 | GO:0042026 | BP | protein refolding |
| 589 | maroon | 76 | 3.1e-03 | 1.000 | 2 | GO:0102567 | MF | phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) |
| 590 | maroon | 76 | 3.1e-03 | 1.000 | 2 | GO:0102568 | MF | phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) |
| 591 | mediumorchid | 59 | 3.0e-04 | 1.000 | 2 | GO:0017185 | BP | peptidyl-lysine hydroxylation |
| 592 | mediumorchid | 59 | 1.9e-03 | 1.000 | 2 | GO:0045956 | BP | positive regulation of calcium ion-dependent exocytosis |
| 593 | mediumorchid | 59 | 1.9e-03 | 1.000 | 2 | GO:0046827 | BP | positive regulation of protein export from nucleus |
| 594 | mediumorchid | 59 | 2.1e-03 | 1.000 | 2 | GO:0018126 | BP | protein hydroxylation |
| 595 | mediumorchid | 59 | 3.7e-03 | 1.000 | 2 | GO:0045777 | BP | positive regulation of blood pressure |
| 596 | mediumorchid | 59 | 3.8e-03 | 1.000 | 1 | GO:0018395 | BP | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine |
| 597 | mediumorchid | 59 | 3.8e-03 | 1.000 | 1 | GO:0031990 | BP | mRNA export from nucleus in response to heat stress |
| 598 | mediumorchid | 59 | 3.8e-03 | 1.000 | 1 | GO:0048697 | BP | positive regulation of collateral sprouting in absence of injury |
| 599 | mediumorchid | 59 | 3.8e-03 | 1.000 | 1 | GO:0060064 | BP | Spemann organizer formation at the anterior end of the primitive streak |
| 600 | mediumorchid | 59 | 3.8e-03 | 1.000 | 1 | GO:0070078 | BP | histone H3-R2 demethylation |
| 601 | mediumpurple1 | 37 | 1.0e-03 | 1.000 | 3 | GO:0006289 | BP | nucleotide-excision repair |
| 602 | mediumpurple1 | 37 | 1.5e-03 | 1.000 | 4 | GO:0070646 | BP | protein modification by small protein removal |
| 603 | mediumpurple1 | 37 | 1.6e-03 | 1.000 | 6 | GO:0007600 | BP | sensory perception |
| 604 | mediumpurple1 | 37 | 1.6e-03 | 1.000 | 2 | GO:0090383 | BP | phagosome acidification |
| 605 | mediumpurple1 | 37 | 2.3e-03 | 1.000 | 5 | GO:0030424 | CC | axon |
| 606 | mediumpurple1 | 37 | 2.3e-03 | 1.000 | 1 | GO:0006463 | BP | steroid hormone receptor complex assembly |
| 607 | mediumpurple1 | 37 | 2.3e-03 | 1.000 | 1 | GO:0032078 | BP | negative regulation of endodeoxyribonuclease activity |
| 608 | mediumpurple1 | 37 | 2.3e-03 | 1.000 | 1 | GO:0043322 | BP | negative regulation of natural killer cell degranulation |
| 609 | mediumpurple1 | 37 | 2.3e-03 | 1.000 | 1 | GO:0030549 | MF | acetylcholine receptor activator activity |
| 610 | mediumpurple1 | 37 | 2.7e-03 | 1.000 | 2 | GO:0090317 | BP | negative regulation of intracellular protein transport |
| 611 | mediumpurple2 | 61 | 1.6e-04 | 1.000 | 2 | GO:1900222 | BP | negative regulation of amyloid-beta clearance |
| 612 | mediumpurple2 | 61 | 7.0e-04 | 1.000 | 13 | GO:0032940 | BP | secretion by cell |
| 613 | mediumpurple2 | 61 | 1.3e-03 | 1.000 | 2 | GO:1900221 | BP | regulation of amyloid-beta clearance |
| 614 | mediumpurple2 | 61 | 1.3e-03 | 1.000 | 9 | GO:0030141 | CC | secretory granule |
| 615 | mediumpurple2 | 61 | 1.6e-03 | 1.000 | 4 | GO:0008203 | BP | cholesterol metabolic process |
| 616 | mediumpurple2 | 61 | 1.6e-03 | 1.000 | 13 | GO:0046903 | BP | secretion |
| 617 | mediumpurple2 | 61 | 1.7e-03 | 1.000 | 3 | GO:0032418 | BP | lysosome localization |
| 618 | mediumpurple2 | 61 | 2.0e-03 | 1.000 | 4 | GO:0016125 | BP | sterol metabolic process |
| 619 | mediumpurple2 | 61 | 2.0e-03 | 1.000 | 3 | GO:0006695 | BP | cholesterol biosynthetic process |
| 620 | mediumpurple2 | 61 | 2.3e-03 | 1.000 | 3 | GO:0016126 | BP | sterol biosynthetic process |
| 621 | mediumpurple3 | 91 | 3.7e-04 | 1.000 | 2 | GO:1904783 | BP | positive regulation of NMDA glutamate receptor activity |
| 622 | mediumpurple3 | 91 | 5.2e-04 | 1.000 | 3 | GO:2000310 | BP | regulation of NMDA receptor activity |
| 623 | mediumpurple3 | 91 | 8.8e-04 | 1.000 | 3 | GO:0030501 | BP | positive regulation of bone mineralization |
| 624 | mediumpurple3 | 91 | 1.0e-03 | 1.000 | 2 | GO:0048703 | BP | embryonic viscerocranium morphogenesis |
| 625 | mediumpurple3 | 91 | 1.0e-03 | 1.000 | 2 | GO:0071313 | BP | cellular response to caffeine |
| 626 | mediumpurple3 | 91 | 1.0e-03 | 1.000 | 2 | GO:0072033 | BP | renal vesicle formation |
| 627 | mediumpurple3 | 91 | 1.2e-03 | 1.000 | 3 | GO:0001974 | BP | blood vessel remodeling |
| 628 | mediumpurple3 | 91 | 1.4e-03 | 1.000 | 3 | GO:0070169 | BP | positive regulation of biomineral tissue development |
| 629 | mediumpurple3 | 91 | 1.5e-03 | 1.000 | 4 | GO:0032414 | BP | positive regulation of ion transmembrane transporter activity |
| 630 | mediumpurple3 | 91 | 1.6e-03 | 1.000 | 2 | GO:0071415 | BP | cellular response to purine-containing compound |
| 631 | mediumpurple4 | 42 | 1.6e-04 | 1.000 | 2 | GO:0071044 | BP | histone mRNA catabolic process |
| 632 | mediumpurple4 | 42 | 4.1e-04 | 1.000 | 2 | GO:0034214 | BP | protein hexamerization |
| 633 | mediumpurple4 | 42 | 1.2e-03 | 1.000 | 2 | GO:0008334 | BP | histone mRNA metabolic process |
| 634 | mediumpurple4 | 42 | 1.5e-03 | 1.000 | 2 | GO:0006884 | BP | cell volume homeostasis |
| 635 | mediumpurple4 | 42 | 1.8e-03 | 1.000 | 18 | GO:0031981 | CC | nuclear lumen |
| 636 | mediumpurple4 | 42 | 2.8e-03 | 1.000 | 1 | GO:0060695 | BP | negative regulation of cholesterol transporter activity |
| 637 | mediumpurple4 | 42 | 2.8e-03 | 1.000 | 1 | GO:0110114 | BP | negative regulation of lipid transporter activity |
| 638 | mediumpurple4 | 42 | 2.8e-03 | 1.000 | 1 | GO:0060072 | MF | large conductance calcium-activated potassium channel activity |
| 639 | mediumpurple4 | 42 | 4.1e-03 | 1.000 | 3 | GO:0071773 | BP | cellular response to BMP stimulus |
| 640 | mediumpurple4 | 42 | 5.6e-03 | 1.000 | 1 | GO:0000294 | BP | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay |
| 641 | midnightblue | 227 | 9.2e-05 | 1.000 | 10 | GO:0048002 | BP | antigen processing and presentation of peptide antigen |
| 642 | midnightblue | 227 | 9.5e-05 | 1.000 | 9 | GO:0031497 | BP | chromatin assembly |
| 643 | midnightblue | 227 | 2.1e-04 | 1.000 | 2 | GO:0031467 | CC | Cul7-RING ubiquitin ligase complex |
| 644 | midnightblue | 227 | 2.2e-04 | 1.000 | 8 | GO:0006334 | BP | nucleosome assembly |
| 645 | midnightblue | 227 | 3.1e-04 | 1.000 | 10 | GO:0019882 | BP | antigen processing and presentation |
| 646 | midnightblue | 227 | 3.6e-04 | 1.000 | 9 | GO:0006333 | BP | chromatin assembly or disassembly |
| 647 | midnightblue | 227 | 5.7e-04 | 1.000 | 9 | GO:0006323 | BP | DNA packaging |
| 648 | midnightblue | 227 | 6.3e-04 | 1.000 | 2 | GO:0042335 | BP | cuticle development |
| 649 | midnightblue | 227 | 8.6e-04 | 1.000 | 8 | GO:0034728 | BP | nucleosome organization |
| 650 | midnightblue | 227 | 9.1e-04 | 1.000 | 22 | GO:0034622 | BP | cellular protein-containing complex assembly |
| 651 | navajowhite1 | 49 | 6.7e-04 | 1.000 | 2 | GO:0016540 | BP | protein autoprocessing |
| 652 | navajowhite1 | 49 | 2.8e-03 | 1.000 | 1 | GO:0010607 | BP | negative regulation of cytoplasmic mRNA processing body assembly |
| 653 | navajowhite1 | 49 | 2.8e-03 | 1.000 | 1 | GO:0043111 | BP | replication fork arrest |
| 654 | navajowhite1 | 49 | 2.8e-03 | 1.000 | 1 | GO:0043541 | CC | UDP-N-acetylglucosamine transferase complex |
| 655 | navajowhite1 | 49 | 5.6e-03 | 1.000 | 1 | GO:0006683 | BP | galactosylceramide catabolic process |
| 656 | navajowhite1 | 49 | 5.6e-03 | 1.000 | 1 | GO:0046041 | BP | ITP metabolic process |
| 657 | navajowhite1 | 49 | 5.6e-03 | 1.000 | 1 | GO:1905373 | BP | ceramide phosphoethanolamine biosynthetic process |
| 658 | navajowhite1 | 49 | 5.6e-03 | 1.000 | 1 | GO:0005745 | CC | m-AAA complex |
| 659 | navajowhite1 | 49 | 5.6e-03 | 1.000 | 1 | GO:0004336 | MF | galactosylceramidase activity |
| 660 | navajowhite1 | 49 | 5.6e-03 | 1.000 | 1 | GO:0033188 | MF | sphingomyelin synthase activity |
| 661 | navajowhite2 | 73 | 2.3e-05 | 0.400 | 2 | GO:0008050 | BP | female courtship behavior |
| 662 | navajowhite2 | 73 | 2.2e-04 | 1.000 | 2 | GO:0099542 | BP | trans-synaptic signaling by endocannabinoid |
| 663 | navajowhite2 | 73 | 2.2e-04 | 1.000 | 2 | GO:0070324 | MF | thyroid hormone binding |
| 664 | navajowhite2 | 73 | 3.4e-04 | 1.000 | 2 | GO:0045924 | BP | regulation of female receptivity |
| 665 | navajowhite2 | 73 | 4.7e-04 | 1.000 | 2 | GO:0060180 | BP | female mating behavior |
| 666 | navajowhite2 | 73 | 5.3e-04 | 1.000 | 9 | GO:0045786 | BP | negative regulation of cell cycle |
| 667 | navajowhite2 | 73 | 2.3e-03 | 1.000 | 2 | GO:2000001 | BP | regulation of DNA damage checkpoint |
| 668 | navajowhite2 | 73 | 2.3e-03 | 1.000 | 2 | GO:0016780 | MF | phosphotransferase activity, for other substituted phosphate groups |
| 669 | navajowhite2 | 73 | 2.6e-03 | 1.000 | 4 | GO:0000077 | BP | DNA damage checkpoint |
| 670 | navajowhite2 | 73 | 2.9e-03 | 1.000 | 5 | GO:0007611 | BP | learning or memory |
| 671 | orange | 123 | 2.2e-04 | 1.000 | 3 | GO:0001991 | BP | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
| 672 | orange | 123 | 3.8e-04 | 1.000 | 2 | GO:0030485 | CC | smooth muscle contractile fiber |
| 673 | orange | 123 | 6.1e-04 | 1.000 | 3 | GO:0003081 | BP | regulation of systemic arterial blood pressure by renin-angiotensin |
| 674 | orange | 123 | 8.0e-04 | 1.000 | 3 | GO:0016486 | BP | peptide hormone processing |
| 675 | orange | 123 | 8.0e-04 | 1.000 | 3 | GO:1901661 | BP | quinone metabolic process |
| 676 | orange | 123 | 9.5e-04 | 1.000 | 2 | GO:0050917 | BP | sensory perception of umami taste |
| 677 | orange | 123 | 1.7e-03 | 1.000 | 2 | GO:0001660 | BP | fever generation |
| 678 | orange | 123 | 2.4e-03 | 1.000 | 4 | GO:0003073 | BP | regulation of systemic arterial blood pressure |
| 679 | orange | 123 | 2.8e-03 | 1.000 | 2 | GO:0002003 | BP | angiotensin maturation |
| 680 | orange | 123 | 2.8e-03 | 1.000 | 2 | GO:0006744 | BP | ubiquinone biosynthetic process |
| 681 | orangered1 | 38 | 1.9e-04 | 1.000 | 3 | GO:0032515 | BP | negative regulation of phosphoprotein phosphatase activity |
| 682 | orangered1 | 38 | 2.3e-04 | 1.000 | 3 | GO:0035308 | BP | negative regulation of protein dephosphorylation |
| 683 | orangered1 | 38 | 4.8e-04 | 1.000 | 3 | GO:1900407 | BP | regulation of cellular response to oxidative stress |
| 684 | orangered1 | 38 | 7.0e-04 | 1.000 | 3 | GO:1902882 | BP | regulation of response to oxidative stress |
| 685 | orangered1 | 38 | 1.2e-03 | 1.000 | 3 | GO:0010923 | BP | negative regulation of phosphatase activity |
| 686 | orangered1 | 38 | 1.3e-03 | 1.000 | 3 | GO:0043666 | BP | regulation of phosphoprotein phosphatase activity |
| 687 | orangered1 | 38 | 1.5e-03 | 1.000 | 3 | GO:0035305 | BP | negative regulation of dephosphorylation |
| 688 | orangered1 | 38 | 2.3e-03 | 1.000 | 3 | GO:0035304 | BP | regulation of protein dephosphorylation |
| 689 | orangered1 | 38 | 2.3e-03 | 1.000 | 2 | GO:1901031 | BP | regulation of response to reactive oxygen species |
| 690 | orangered1 | 38 | 2.6e-03 | 1.000 | 1 | GO:0006173 | BP | dADP biosynthetic process |
| 691 | orangered3 | 54 | 1.3e-04 | 1.000 | 2 | GO:0000820 | BP | regulation of glutamine family amino acid metabolic process |
| 692 | orangered3 | 54 | 4.5e-04 | 1.000 | 2 | GO:0009086 | BP | methionine biosynthetic process |
| 693 | orangered3 | 54 | 5.6e-04 | 1.000 | 26 | GO:0007275 | BP | multicellular organism development |
| 694 | orangered3 | 54 | 5.9e-04 | 1.000 | 12 | GO:0030030 | BP | cell projection organization |
| 695 | orangered3 | 54 | 6.9e-04 | 1.000 | 2 | GO:0086103 | BP | G protein-coupled receptor signaling pathway involved in heart process |
| 696 | orangered3 | 54 | 7.0e-04 | 1.000 | 24 | GO:0048731 | BP | system development |
| 697 | orangered3 | 54 | 8.2e-04 | 1.000 | 9 | GO:0031175 | BP | neuron projection development |
| 698 | orangered3 | 54 | 9.7e-04 | 1.000 | 2 | GO:0000097 | BP | sulfur amino acid biosynthetic process |
| 699 | orangered3 | 54 | 1.1e-03 | 1.000 | 2 | GO:0006555 | BP | methionine metabolic process |
| 700 | orangered3 | 54 | 1.3e-03 | 1.000 | 3 | GO:0008652 | BP | cellular amino acid biosynthetic process |
| 701 | orangered4 | 92 | 3.5e-04 | 1.000 | 3 | GO:0002063 | BP | chondrocyte development |
| 702 | orangered4 | 92 | 3.6e-04 | 1.000 | 2 | GO:0004468 | MF | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| 703 | orangered4 | 92 | 7.7e-04 | 1.000 | 3 | GO:0000183 | BP | chromatin silencing at rDNA |
| 704 | orangered4 | 92 | 9.9e-04 | 1.000 | 2 | GO:0030955 | MF | potassium ion binding |
| 705 | orangered4 | 92 | 1.2e-03 | 1.000 | 3 | GO:0050840 | MF | extracellular matrix binding |
| 706 | orangered4 | 92 | 1.3e-03 | 1.000 | 2 | GO:0090520 | BP | sphingolipid mediated signaling pathway |
| 707 | orangered4 | 92 | 2.0e-03 | 1.000 | 4 | GO:0098693 | BP | regulation of synaptic vesicle cycle |
| 708 | orangered4 | 92 | 2.2e-03 | 1.000 | 3 | GO:0042771 | BP | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| 709 | orangered4 | 92 | 2.7e-03 | 1.000 | 2 | GO:0045717 | BP | negative regulation of fatty acid biosynthetic process |
| 710 | orangered4 | 92 | 2.8e-03 | 1.000 | 17 | GO:0040011 | BP | locomotion |
| 711 | paleturquoise | 113 | 1.8e-03 | 1.000 | 2 | GO:0032052 | MF | bile acid binding |
| 712 | paleturquoise | 113 | 3.2e-03 | 1.000 | 3 | GO:0007062 | BP | sister chromatid cohesion |
| 713 | paleturquoise | 113 | 4.4e-03 | 1.000 | 2 | GO:0005545 | MF | 1-phosphatidylinositol binding |
| 714 | paleturquoise | 113 | 7.2e-03 | 1.000 | 1 | GO:0002882 | BP | positive regulation of chronic inflammatory response to non-antigenic stimulus |
| 715 | paleturquoise | 113 | 7.2e-03 | 1.000 | 1 | GO:0006789 | BP | bilirubin conjugation |
| 716 | paleturquoise | 113 | 7.2e-03 | 1.000 | 1 | GO:0010021 | BP | amylopectin biosynthetic process |
| 717 | paleturquoise | 113 | 7.2e-03 | 1.000 | 1 | GO:0044328 | BP | canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration |
| 718 | paleturquoise | 113 | 7.2e-03 | 1.000 | 1 | GO:0044329 | BP | canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion |
| 719 | paleturquoise | 113 | 7.2e-03 | 1.000 | 1 | GO:0044330 | BP | canonical Wnt signaling pathway involved in positive regulation of wound healing |
| 720 | paleturquoise | 113 | 7.2e-03 | 1.000 | 1 | GO:0044381 | BP | glucose import in response to insulin stimulus |
| 721 | palevioletred1 | 28 | 2.0e-05 | 0.350 | 2 | GO:0002605 | BP | negative regulation of dendritic cell antigen processing and presentation |
| 722 | palevioletred1 | 28 | 1.2e-04 | 1.000 | 2 | GO:0002578 | BP | negative regulation of antigen processing and presentation |
| 723 | palevioletred1 | 28 | 9.1e-04 | 1.000 | 2 | GO:0071813 | MF | lipoprotein particle binding |
| 724 | palevioletred1 | 28 | 1.1e-03 | 1.000 | 2 | GO:0030511 | BP | positive regulation of transforming growth factor beta receptor signaling pathway |
| 725 | palevioletred1 | 28 | 1.1e-03 | 1.000 | 5 | GO:0006935 | BP | chemotaxis |
| 726 | palevioletred1 | 28 | 1.6e-03 | 1.000 | 3 | GO:0005840 | CC | ribosome |
| 727 | palevioletred1 | 28 | 1.8e-03 | 1.000 | 2 | GO:0050922 | BP | negative regulation of chemotaxis |
| 728 | palevioletred1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0001811 | BP | negative regulation of type I hypersensitivity |
| 729 | palevioletred1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0001814 | BP | negative regulation of antibody-dependent cellular cytotoxicity |
| 730 | palevioletred1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0002622 | BP | regulation of B cell antigen processing and presentation |
| 731 | palevioletred2 | 49 | 6.1e-04 | 1.000 | 5 | GO:0005765 | CC | lysosomal membrane |
| 732 | palevioletred2 | 49 | 6.3e-04 | 1.000 | 5 | GO:0015631 | MF | tubulin binding |
| 733 | palevioletred2 | 49 | 8.0e-04 | 1.000 | 3 | GO:0019674 | BP | NAD metabolic process |
| 734 | palevioletred2 | 49 | 1.1e-03 | 1.000 | 2 | GO:0050860 | BP | negative regulation of T cell receptor signaling pathway |
| 735 | palevioletred2 | 49 | 1.1e-03 | 1.000 | 4 | GO:0008017 | MF | microtubule binding |
| 736 | palevioletred2 | 49 | 1.2e-03 | 1.000 | 5 | GO:0005774 | CC | vacuolar membrane |
| 737 | palevioletred2 | 49 | 1.6e-03 | 1.000 | 5 | GO:0045121 | CC | membrane raft |
| 738 | palevioletred2 | 49 | 1.6e-03 | 1.000 | 5 | GO:0098857 | CC | membrane microdomain |
| 739 | palevioletred2 | 49 | 1.7e-03 | 1.000 | 2 | GO:0019054 | BP | modulation by virus of host process |
| 740 | palevioletred2 | 49 | 1.7e-03 | 1.000 | 2 | GO:0032703 | BP | negative regulation of interleukin-2 production |
| 741 | palevioletred3 | 77 | 2.5e-05 | 0.430 | 2 | GO:0003169 | BP | coronary vein morphogenesis |
| 742 | palevioletred3 | 77 | 2.5e-05 | 0.430 | 2 | GO:0060948 | BP | cardiac vascular smooth muscle cell development |
| 743 | palevioletred3 | 77 | 3.7e-04 | 1.000 | 2 | GO:0061419 | BP | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| 744 | palevioletred3 | 77 | 3.7e-04 | 1.000 | 2 | GO:0097084 | BP | vascular smooth muscle cell development |
| 745 | palevioletred3 | 77 | 3.7e-04 | 1.000 | 2 | GO:0120009 | BP | intermembrane lipid transfer |
| 746 | palevioletred3 | 77 | 5.1e-04 | 1.000 | 2 | GO:0060947 | BP | cardiac vascular smooth muscle cell differentiation |
| 747 | palevioletred3 | 77 | 5.1e-04 | 1.000 | 2 | GO:0120013 | MF | intermembrane lipid transfer activity |
| 748 | palevioletred3 | 77 | 6.8e-04 | 1.000 | 2 | GO:0060982 | BP | coronary artery morphogenesis |
| 749 | palevioletred3 | 77 | 8.7e-04 | 1.000 | 2 | GO:0048845 | BP | venous blood vessel morphogenesis |
| 750 | palevioletred3 | 77 | 8.9e-04 | 1.000 | 3 | GO:0007595 | BP | lactation |
| 751 | pink | 324 | 4.6e-04 | 1.000 | 2 | GO:0015379 | MF | potassium:chloride symporter activity |
| 752 | pink | 324 | 7.4e-04 | 1.000 | 3 | GO:0006971 | BP | hypotonic response |
| 753 | pink | 324 | 1.3e-03 | 1.000 | 4 | GO:0045214 | BP | sarcomere organization |
| 754 | pink | 324 | 2.7e-03 | 1.000 | 2 | GO:0030240 | BP | skeletal muscle thin filament assembly |
| 755 | pink | 324 | 2.7e-03 | 1.000 | 2 | GO:0044860 | BP | protein localization to plasma membrane raft |
| 756 | pink | 324 | 2.7e-03 | 1.000 | 2 | GO:0046085 | BP | adenosine metabolic process |
| 757 | pink | 324 | 2.7e-03 | 1.000 | 2 | GO:0051121 | BP | hepoxilin metabolic process |
| 758 | pink | 324 | 2.7e-03 | 1.000 | 2 | GO:0051122 | BP | hepoxilin biosynthetic process |
| 759 | pink | 324 | 2.7e-03 | 1.000 | 2 | GO:0051594 | BP | detection of glucose |
| 760 | pink | 324 | 2.7e-03 | 1.000 | 2 | GO:1901979 | BP | regulation of inward rectifier potassium channel activity |
| 761 | pink4 | 37 | 7.1e-04 | 1.000 | 2 | GO:0045663 | BP | positive regulation of myoblast differentiation |
| 762 | pink4 | 37 | 1.7e-03 | 1.000 | 7 | GO:0008284 | BP | positive regulation of cell proliferation |
| 763 | pink4 | 37 | 2.5e-03 | 1.000 | 1 | GO:0010164 | BP | response to cesium ion |
| 764 | pink4 | 37 | 2.5e-03 | 1.000 | 1 | GO:0090290 | BP | positive regulation of osteoclast proliferation |
| 765 | pink4 | 37 | 2.5e-03 | 1.000 | 1 | GO:0150007 | BP | clathrin-dependent synaptic vesicle endocytosis |
| 766 | pink4 | 37 | 2.5e-03 | 1.000 | 1 | GO:1990456 | BP | mitochondrion-endoplasmic reticulum membrane tethering |
| 767 | pink4 | 37 | 3.2e-03 | 1.000 | 2 | GO:0008631 | BP | intrinsic apoptotic signaling pathway in response to oxidative stress |
| 768 | pink4 | 37 | 3.9e-03 | 1.000 | 3 | GO:0005882 | CC | intermediate filament |
| 769 | pink4 | 37 | 4.9e-03 | 1.000 | 2 | GO:0008333 | BP | endosome to lysosome transport |
| 770 | pink4 | 37 | 4.9e-03 | 1.000 | 2 | GO:0072577 | BP | endothelial cell apoptotic process |
| 771 | plum | 61 | 3.2e-04 | 1.000 | 2 | GO:1990247 | MF | N6-methyladenosine-containing RNA binding |
| 772 | plum | 61 | 1.2e-03 | 1.000 | 5 | GO:0070085 | BP | glycosylation |
| 773 | plum | 61 | 2.8e-03 | 1.000 | 2 | GO:2000765 | BP | regulation of cytoplasmic translation |
| 774 | plum | 61 | 3.4e-03 | 1.000 | 2 | GO:0045948 | BP | positive regulation of translational initiation |
| 775 | plum | 61 | 4.0e-03 | 1.000 | 1 | GO:0005983 | BP | starch catabolic process |
| 776 | plum | 61 | 4.0e-03 | 1.000 | 1 | GO:0046588 | BP | negative regulation of calcium-dependent cell-cell adhesion |
| 777 | plum | 61 | 4.0e-03 | 1.000 | 1 | GO:1900139 | BP | negative regulation of arachidonic acid secretion |
| 778 | plum | 61 | 4.0e-03 | 1.000 | 1 | GO:1900148 | BP | negative regulation of Schwann cell migration |
| 779 | plum | 61 | 4.0e-03 | 1.000 | 1 | GO:1902153 | BP | regulation of response to DNA damage checkpoint signaling |
| 780 | plum | 61 | 4.0e-03 | 1.000 | 1 | GO:1903538 | BP | regulation of meiotic cell cycle process involved in oocyte maturation |
| 781 | plum1 | 92 | 1.9e-04 | 1.000 | 3 | GO:0042273 | BP | ribosomal large subunit biogenesis |
| 782 | plum1 | 92 | 2.2e-04 | 1.000 | 4 | GO:0000932 | CC | P-body |
| 783 | plum1 | 92 | 4.8e-04 | 1.000 | 3 | GO:0032633 | BP | interleukin-4 production |
| 784 | plum1 | 92 | 9.7e-04 | 1.000 | 2 | GO:0000176 | CC | nuclear exosome (RNase complex) |
| 785 | plum1 | 92 | 9.9e-04 | 1.000 | 4 | GO:0002821 | BP | positive regulation of adaptive immune response |
| 786 | plum1 | 92 | 1.2e-03 | 1.000 | 2 | GO:2000318 | BP | positive regulation of T-helper 17 type immune response |
| 787 | plum1 | 92 | 1.4e-03 | 1.000 | 10 | GO:1990904 | CC | ribonucleoprotein complex |
| 788 | plum1 | 92 | 1.5e-03 | 1.000 | 3 | GO:0032653 | BP | regulation of interleukin-10 production |
| 789 | plum1 | 92 | 1.5e-03 | 1.000 | 2 | GO:0000460 | BP | maturation of 5.8S rRNA |
| 790 | plum1 | 92 | 1.8e-03 | 1.000 | 5 | GO:0036464 | CC | cytoplasmic ribonucleoprotein granule |
| 791 | plum2 | 77 | 1.1e-03 | 1.000 | 2 | GO:0015037 | MF | peptide disulfide oxidoreductase activity |
| 792 | plum2 | 77 | 2.2e-03 | 1.000 | 2 | GO:0000339 | MF | RNA cap binding |
| 793 | plum2 | 77 | 2.5e-03 | 1.000 | 13 | GO:0016477 | BP | cell migration |
| 794 | plum2 | 77 | 4.9e-03 | 1.000 | 2 | GO:0000993 | MF | RNA polymerase II complex binding |
| 795 | plum2 | 77 | 5.0e-03 | 1.000 | 1 | GO:0002926 | BP | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation |
| 796 | plum2 | 77 | 5.0e-03 | 1.000 | 1 | GO:0008218 | BP | bioluminescence |
| 797 | plum2 | 77 | 5.0e-03 | 1.000 | 1 | GO:0046491 | BP | L-methylmalonyl-CoA metabolic process |
| 798 | plum2 | 77 | 5.0e-03 | 1.000 | 1 | GO:0060010 | BP | Sertoli cell fate commitment |
| 799 | plum2 | 77 | 5.0e-03 | 1.000 | 1 | GO:0072356 | BP | chromosome passenger complex localization to kinetochore |
| 800 | plum2 | 77 | 5.0e-03 | 1.000 | 1 | GO:0090625 | BP | mRNA cleavage involved in gene silencing by siRNA |
| 801 | plum3 | 60 | 1.4e-03 | 1.000 | 2 | GO:0061952 | BP | midbody abscission |
| 802 | plum3 | 60 | 1.4e-03 | 1.000 | 2 | GO:1903830 | BP | magnesium ion transmembrane transport |
| 803 | plum3 | 60 | 1.4e-03 | 1.000 | 2 | GO:0015095 | MF | magnesium ion transmembrane transporter activity |
| 804 | plum3 | 60 | 1.6e-03 | 1.000 | 2 | GO:0015693 | BP | magnesium ion transport |
| 805 | plum3 | 60 | 2.2e-03 | 1.000 | 3 | GO:0000018 | BP | regulation of DNA recombination |
| 806 | plum3 | 60 | 2.2e-03 | 1.000 | 3 | GO:0048199 | BP | vesicle targeting, to, from or within Golgi |
| 807 | plum3 | 60 | 2.9e-03 | 1.000 | 2 | GO:0034453 | BP | microtubule anchoring |
| 808 | plum3 | 60 | 2.9e-03 | 1.000 | 2 | GO:1902410 | BP | mitotic cytokinetic process |
| 809 | plum3 | 60 | 4.0e-03 | 1.000 | 4 | GO:0050870 | BP | positive regulation of T cell activation |
| 810 | plum3 | 60 | 4.0e-03 | 1.000 | 1 | GO:0010814 | BP | substance P catabolic process |
| 811 | plum4 | 27 | 4.3e-05 | 0.750 | 5 | GO:0050863 | BP | regulation of T cell activation |
| 812 | plum4 | 27 | 1.2e-04 | 1.000 | 3 | GO:1902036 | BP | regulation of hematopoietic stem cell differentiation |
| 813 | plum4 | 27 | 1.5e-04 | 1.000 | 2 | GO:0045176 | BP | apical protein localization |
| 814 | plum4 | 27 | 1.6e-04 | 1.000 | 5 | GO:0051249 | BP | regulation of lymphocyte activation |
| 815 | plum4 | 27 | 1.8e-04 | 1.000 | 3 | GO:0060218 | BP | hematopoietic stem cell differentiation |
| 816 | plum4 | 27 | 2.2e-04 | 1.000 | 3 | GO:1901532 | BP | regulation of hematopoietic progenitor cell differentiation |
| 817 | plum4 | 27 | 2.8e-04 | 1.000 | 5 | GO:0042110 | BP | T cell activation |
| 818 | plum4 | 27 | 3.2e-04 | 1.000 | 2 | GO:0045624 | BP | positive regulation of T-helper cell differentiation |
| 819 | plum4 | 27 | 3.5e-04 | 1.000 | 5 | GO:1903706 | BP | regulation of hemopoiesis |
| 820 | plum4 | 27 | 4.8e-04 | 1.000 | 3 | GO:2000736 | BP | regulation of stem cell differentiation |
| 821 | purple | 281 | 3.7e-05 | 0.650 | 12 | GO:0030027 | CC | lamellipodium |
| 822 | purple | 281 | 1.1e-04 | 1.000 | 17 | GO:0031252 | CC | cell leading edge |
| 823 | purple | 281 | 1.2e-04 | 1.000 | 3 | GO:0030868 | CC | smooth endoplasmic reticulum membrane |
| 824 | purple | 281 | 2.5e-04 | 1.000 | 17 | GO:0015629 | CC | actin cytoskeleton |
| 825 | purple | 281 | 2.7e-04 | 1.000 | 6 | GO:0030032 | BP | lamellipodium assembly |
| 826 | purple | 281 | 5.8e-04 | 1.000 | 10 | GO:0006367 | BP | transcription initiation from RNA polymerase II promoter |
| 827 | purple | 281 | 7.7e-04 | 1.000 | 4 | GO:0010591 | BP | regulation of lamellipodium assembly |
| 828 | purple | 281 | 1.0e-03 | 1.000 | 2 | GO:0003987 | MF | acetate-CoA ligase activity |
| 829 | purple | 281 | 1.0e-03 | 1.000 | 2 | GO:0102485 | MF | dATP phosphohydrolase activity |
| 830 | purple | 281 | 1.0e-03 | 1.000 | 2 | GO:0102486 | MF | dCTP phosphohydrolase activity |
| 831 | red | 610 | 1.1e-03 | 1.000 | 3 | GO:0070728 | MF | leucine binding |
| 832 | red | 610 | 1.6e-03 | 1.000 | 2 | GO:0097114 | BP | NMDA glutamate receptor clustering |
| 833 | red | 610 | 2.4e-03 | 1.000 | 4 | GO:0051782 | BP | negative regulation of cell division |
| 834 | red | 610 | 3.0e-03 | 1.000 | 3 | GO:0098787 | BP | mRNA cleavage involved in mRNA processing |
| 835 | red | 610 | 3.2e-03 | 1.000 | 5 | GO:0032692 | BP | negative regulation of interleukin-1 production |
| 836 | red | 610 | 3.9e-03 | 1.000 | 4 | GO:0005868 | CC | cytoplasmic dynein complex |
| 837 | red | 610 | 4.4e-03 | 1.000 | 3 | GO:0000808 | CC | origin recognition complex |
| 838 | red | 610 | 4.6e-03 | 1.000 | 2 | GO:1902952 | BP | positive regulation of dendritic spine maintenance |
| 839 | red | 610 | 4.6e-03 | 1.000 | 2 | GO:0008282 | CC | inward rectifying potassium channel |
| 840 | red | 610 | 4.7e-03 | 1.000 | 9 | GO:0007156 | BP | homophilic cell adhesion via plasma membrane adhesion molecules |
| 841 | royalblue | 156 | 8.0e-05 | 1.000 | 9 | GO:0002064 | BP | epithelial cell development |
| 842 | royalblue | 156 | 1.1e-04 | 1.000 | 4 | GO:0060740 | BP | prostate gland epithelium morphogenesis |
| 843 | royalblue | 156 | 1.5e-04 | 1.000 | 4 | GO:0060512 | BP | prostate gland morphogenesis |
| 844 | royalblue | 156 | 3.9e-04 | 1.000 | 3 | GO:0046965 | MF | retinoid X receptor binding |
| 845 | royalblue | 156 | 8.0e-04 | 1.000 | 5 | GO:0034446 | BP | substrate adhesion-dependent cell spreading |
| 846 | royalblue | 156 | 8.4e-04 | 1.000 | 3 | GO:0015248 | MF | sterol transporter activity |
| 847 | royalblue | 156 | 9.8e-04 | 1.000 | 4 | GO:0030850 | BP | prostate gland development |
| 848 | royalblue | 156 | 1.3e-03 | 1.000 | 3 | GO:0042974 | MF | retinoic acid receptor binding |
| 849 | royalblue | 156 | 1.4e-03 | 1.000 | 5 | GO:0002062 | BP | chondrocyte differentiation |
| 850 | royalblue | 156 | 1.6e-03 | 1.000 | 2 | GO:0001547 | BP | antral ovarian follicle growth |
| 851 | saddlebrown | 118 | 8.3e-06 | 0.150 | 3 | GO:0003357 | BP | noradrenergic neuron differentiation |
| 852 | saddlebrown | 118 | 1.7e-04 | 1.000 | 2 | GO:0002378 | BP | immunoglobulin biosynthetic process |
| 853 | saddlebrown | 118 | 2.7e-04 | 1.000 | 3 | GO:0005980 | BP | glycogen catabolic process |
| 854 | saddlebrown | 118 | 2.7e-04 | 1.000 | 3 | GO:0048485 | BP | sympathetic nervous system development |
| 855 | saddlebrown | 118 | 3.4e-04 | 1.000 | 2 | GO:0045085 | BP | negative regulation of interleukin-2 biosynthetic process |
| 856 | saddlebrown | 118 | 3.7e-04 | 1.000 | 5 | GO:0042035 | BP | regulation of cytokine biosynthetic process |
| 857 | saddlebrown | 118 | 5.1e-04 | 1.000 | 3 | GO:0000272 | BP | polysaccharide catabolic process |
| 858 | saddlebrown | 118 | 5.6e-04 | 1.000 | 2 | GO:0005981 | BP | regulation of glycogen catabolic process |
| 859 | saddlebrown | 118 | 5.6e-04 | 1.000 | 2 | GO:0045590 | BP | negative regulation of regulatory T cell differentiation |
| 860 | saddlebrown | 118 | 5.7e-04 | 1.000 | 5 | GO:0042089 | BP | cytokine biosynthetic process |
| 861 | salmon | 240 | 3.2e-06 | 0.056 | 8 | GO:0043967 | BP | histone H4 acetylation |
| 862 | salmon | 240 | 2.5e-04 | 1.000 | 9 | GO:0016573 | BP | histone acetylation |
| 863 | salmon | 240 | 3.1e-04 | 1.000 | 9 | GO:0018393 | BP | internal peptidyl-lysine acetylation |
| 864 | salmon | 240 | 3.9e-04 | 1.000 | 9 | GO:0006475 | BP | internal protein amino acid acetylation |
| 865 | salmon | 240 | 4.7e-04 | 1.000 | 9 | GO:0018394 | BP | peptidyl-lysine acetylation |
| 866 | salmon | 240 | 5.1e-04 | 1.000 | 14 | GO:0018205 | BP | peptidyl-lysine modification |
| 867 | salmon | 240 | 7.3e-04 | 1.000 | 2 | GO:0032385 | BP | positive regulation of intracellular cholesterol transport |
| 868 | salmon | 240 | 9.7e-04 | 1.000 | 3 | GO:0043968 | BP | histone H2A acetylation |
| 869 | salmon | 240 | 1.2e-03 | 1.000 | 9 | GO:0006473 | BP | protein acetylation |
| 870 | salmon | 240 | 1.3e-03 | 1.000 | 5 | GO:0043966 | BP | histone H3 acetylation |
| 871 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0071602 | BP | phytosphingosine biosynthetic process |
| 872 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:1905711 | BP | response to phosphatidylethanolamine |
| 873 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0004146 | MF | dihydrofolate reductase activity |
| 874 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0019119 | MF | phenanthrene-9,10-epoxide hydrolase activity |
| 875 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0043337 | MF | CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity |
| 876 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0044377 | MF | RNA polymerase II proximal promoter sequence-specific DNA binding, bending |
| 877 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0070774 | MF | phytoceramidase activity |
| 878 | salmon1 | 28 | 3.9e-03 | 1.000 | 1 | GO:0046452 | BP | dihydrofolate metabolic process |
| 879 | salmon1 | 28 | 3.9e-03 | 1.000 | 1 | GO:0019948 | MF | SUMO activating enzyme activity |
| 880 | salmon1 | 28 | 3.9e-03 | 1.000 | 1 | GO:0047144 | MF | 2-acylglycerol-3-phosphate O-acyltransferase activity |
| 881 | salmon2 | 48 | 2.5e-04 | 1.000 | 2 | GO:0033268 | CC | node of Ranvier |
| 882 | salmon2 | 48 | 3.2e-04 | 1.000 | 2 | GO:0043194 | CC | axon initial segment |
| 883 | salmon2 | 48 | 1.2e-03 | 1.000 | 2 | GO:0051497 | BP | negative regulation of stress fiber assembly |
| 884 | salmon2 | 48 | 1.5e-03 | 1.000 | 2 | GO:0032232 | BP | negative regulation of actin filament bundle assembly |
| 885 | salmon2 | 48 | 1.7e-03 | 1.000 | 2 | GO:0043015 | MF | gamma-tubulin binding |
| 886 | salmon2 | 48 | 2.0e-03 | 1.000 | 2 | GO:0018200 | BP | peptidyl-glutamic acid modification |
| 887 | salmon2 | 48 | 2.1e-03 | 1.000 | 3 | GO:0120162 | BP | positive regulation of cold-induced thermogenesis |
| 888 | salmon2 | 48 | 2.2e-03 | 1.000 | 2 | GO:0009925 | CC | basal plasma membrane |
| 889 | salmon2 | 48 | 3.1e-03 | 1.000 | 1 | GO:0021512 | BP | spinal cord anterior/posterior patterning |
| 890 | salmon2 | 48 | 3.1e-03 | 1.000 | 1 | GO:0072660 | BP | maintenance of protein location in plasma membrane |
| 891 | salmon4 | 76 | 5.0e-04 | 1.000 | 2 | GO:0090240 | BP | positive regulation of histone H4 acetylation |
| 892 | salmon4 | 76 | 1.5e-03 | 1.000 | 2 | GO:0090239 | BP | regulation of histone H4 acetylation |
| 893 | salmon4 | 76 | 4.3e-03 | 1.000 | 2 | GO:0071377 | BP | cellular response to glucagon stimulus |
| 894 | salmon4 | 76 | 4.9e-03 | 1.000 | 1 | GO:0002300 | BP | CD8-positive, alpha-beta intraepithelial T cell differentiation |
| 895 | salmon4 | 76 | 4.9e-03 | 1.000 | 1 | GO:0060819 | BP | inactivation of X chromosome by genetic imprinting |
| 896 | salmon4 | 76 | 4.9e-03 | 1.000 | 1 | GO:0120012 | BP | intermembrane sphingolipid transfer |
| 897 | salmon4 | 76 | 4.9e-03 | 1.000 | 1 | GO:1905152 | BP | positive regulation of voltage-gated sodium channel activity |
| 898 | salmon4 | 76 | 4.9e-03 | 1.000 | 1 | GO:0014801 | CC | longitudinal sarcoplasmic reticulum |
| 899 | salmon4 | 76 | 4.9e-03 | 1.000 | 1 | GO:0001226 | MF | RNA polymerase II transcription corepressor binding |
| 900 | salmon4 | 76 | 4.9e-03 | 1.000 | 1 | GO:0004967 | MF | glucagon receptor activity |
| 901 | sienna3 | 98 | 2.4e-03 | 1.000 | 2 | GO:0045120 | CC | pronucleus |
| 902 | sienna3 | 98 | 3.9e-03 | 1.000 | 5 | GO:0031424 | BP | keratinization |
| 903 | sienna3 | 98 | 5.2e-03 | 1.000 | 2 | GO:0015662 | MF | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism |
| 904 | sienna3 | 98 | 6.8e-03 | 1.000 | 1 | GO:0019265 | BP | glycine biosynthetic process, by transamination of glyoxylate |
| 905 | sienna3 | 98 | 6.8e-03 | 1.000 | 1 | GO:0019481 | BP | L-alanine catabolic process, by transamination |
| 906 | sienna3 | 98 | 6.8e-03 | 1.000 | 1 | GO:0036333 | BP | hepatocyte homeostasis |
| 907 | sienna3 | 98 | 6.8e-03 | 1.000 | 1 | GO:0098886 | BP | modification of dendritic spine |
| 908 | sienna3 | 98 | 6.8e-03 | 1.000 | 1 | GO:0099588 | BP | positive regulation of postsynaptic cytosolic calcium concentration |
| 909 | sienna3 | 98 | 6.8e-03 | 1.000 | 1 | GO:1904772 | BP | response to tetrachloromethane |
| 910 | sienna3 | 98 | 6.8e-03 | 1.000 | 1 | GO:2000691 | BP | negative regulation of cardiac muscle cell myoblast differentiation |
| 911 | sienna4 | 39 | 2.4e-04 | 1.000 | 2 | GO:0031629 | BP | synaptic vesicle fusion to presynaptic active zone membrane |
| 912 | sienna4 | 39 | 2.4e-04 | 1.000 | 2 | GO:0099500 | BP | vesicle fusion to plasma membrane |
| 913 | sienna4 | 39 | 2.8e-04 | 1.000 | 5 | GO:0051650 | BP | establishment of vesicle localization |
| 914 | sienna4 | 39 | 3.7e-04 | 1.000 | 5 | GO:0051648 | BP | vesicle localization |
| 915 | sienna4 | 39 | 4.3e-04 | 1.000 | 7 | GO:0051640 | BP | organelle localization |
| 916 | sienna4 | 39 | 4.6e-04 | 1.000 | 6 | GO:0051656 | BP | establishment of organelle localization |
| 917 | sienna4 | 39 | 1.3e-03 | 1.000 | 2 | GO:0003351 | BP | epithelial cilium movement |
| 918 | sienna4 | 39 | 1.3e-03 | 1.000 | 2 | GO:0031338 | BP | regulation of vesicle fusion |
| 919 | sienna4 | 39 | 1.3e-03 | 1.000 | 3 | GO:0016079 | BP | synaptic vesicle exocytosis |
| 920 | sienna4 | 39 | 1.8e-03 | 1.000 | 2 | GO:0098901 | BP | regulation of cardiac muscle cell action potential |
| 921 | skyblue | 119 | 7.0e-04 | 1.000 | 6 | GO:0030308 | BP | negative regulation of cell growth |
| 922 | skyblue | 119 | 2.3e-03 | 1.000 | 4 | GO:0030165 | MF | PDZ domain binding |
| 923 | skyblue | 119 | 2.6e-03 | 1.000 | 37 | GO:0030154 | BP | cell differentiation |
| 924 | skyblue | 119 | 2.6e-03 | 1.000 | 2 | GO:0033860 | BP | regulation of NAD(P)H oxidase activity |
| 925 | skyblue | 119 | 3.0e-03 | 1.000 | 3 | GO:0022602 | BP | ovulation cycle process |
| 926 | skyblue | 119 | 3.2e-03 | 1.000 | 2 | GO:0106074 | BP | aminoacyl-tRNA metabolism involved in translational fidelity |
| 927 | skyblue | 119 | 3.9e-03 | 1.000 | 8 | GO:0001558 | BP | regulation of cell growth |
| 928 | skyblue | 119 | 4.5e-03 | 1.000 | 2 | GO:0006450 | BP | regulation of translational fidelity |
| 929 | skyblue | 119 | 4.8e-03 | 1.000 | 18 | GO:0005739 | CC | mitochondrion |
| 930 | skyblue | 119 | 5.2e-03 | 1.000 | 2 | GO:0010744 | BP | positive regulation of macrophage derived foam cell differentiation |
| 931 | skyblue1 | 64 | 1.9e-06 | 0.033 | 6 | GO:0035335 | BP | peptidyl-tyrosine dephosphorylation |
| 932 | skyblue1 | 64 | 2.2e-05 | 0.380 | 5 | GO:0004725 | MF | protein tyrosine phosphatase activity |
| 933 | skyblue1 | 64 | 2.5e-05 | 0.440 | 6 | GO:0004721 | MF | phosphoprotein phosphatase activity |
| 934 | skyblue1 | 64 | 1.0e-04 | 1.000 | 7 | GO:0006470 | BP | protein dephosphorylation |
| 935 | skyblue1 | 64 | 1.2e-04 | 1.000 | 7 | GO:0042578 | MF | phosphoric ester hydrolase activity |
| 936 | skyblue1 | 64 | 1.7e-04 | 1.000 | 6 | GO:0016791 | MF | phosphatase activity |
| 937 | skyblue1 | 64 | 3.9e-04 | 1.000 | 3 | GO:0008138 | MF | protein tyrosine/serine/threonine phosphatase activity |
| 938 | skyblue1 | 64 | 6.4e-04 | 1.000 | 3 | GO:0016627 | MF | oxidoreductase activity, acting on the CH-CH group of donors |
| 939 | skyblue1 | 64 | 7.8e-04 | 1.000 | 2 | GO:0000050 | BP | urea cycle |
| 940 | skyblue1 | 64 | 1.1e-03 | 1.000 | 7 | GO:0016311 | BP | dephosphorylation |
| 941 | skyblue2 | 56 | 1.2e-03 | 1.000 | 3 | GO:0002039 | MF | p53 binding |
| 942 | skyblue2 | 56 | 2.0e-03 | 1.000 | 2 | GO:1900120 | BP | regulation of receptor binding |
| 943 | skyblue2 | 56 | 2.3e-03 | 1.000 | 2 | GO:0032376 | BP | positive regulation of cholesterol transport |
| 944 | skyblue2 | 56 | 3.8e-03 | 1.000 | 1 | GO:0007072 | BP | positive regulation of transcription involved in exit from mitosis |
| 945 | skyblue2 | 56 | 3.8e-03 | 1.000 | 1 | GO:0042247 | BP | establishment of planar polarity of follicular epithelium |
| 946 | skyblue2 | 56 | 3.8e-03 | 1.000 | 1 | GO:0042669 | BP | regulation of inner ear auditory receptor cell fate specification |
| 947 | skyblue2 | 56 | 3.8e-03 | 1.000 | 1 | GO:0044147 | BP | negative regulation of development of symbiont involved in interaction with host |
| 948 | skyblue2 | 56 | 3.8e-03 | 1.000 | 1 | GO:0044356 | BP | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine |
| 949 | skyblue2 | 56 | 3.8e-03 | 1.000 | 1 | GO:0044795 | BP | trans-Golgi network to recycling endosome transport |
| 950 | skyblue2 | 56 | 3.8e-03 | 1.000 | 1 | GO:0052362 | BP | catabolism by host of symbiont protein |
| 951 | skyblue3 | 93 | 1.1e-04 | 1.000 | 2 | GO:0035166 | BP | post-embryonic hemopoiesis |
| 952 | skyblue3 | 93 | 2.4e-03 | 1.000 | 4 | GO:2000134 | BP | negative regulation of G1/S transition of mitotic cell cycle |
| 953 | skyblue3 | 93 | 2.7e-03 | 1.000 | 2 | GO:0051412 | BP | response to corticosterone |
| 954 | skyblue3 | 93 | 2.7e-03 | 1.000 | 4 | GO:1902807 | BP | negative regulation of cell cycle G1/S phase transition |
| 955 | skyblue3 | 93 | 3.6e-03 | 1.000 | 2 | GO:0002070 | BP | epithelial cell maturation |
| 956 | skyblue3 | 93 | 3.6e-03 | 1.000 | 2 | GO:0006144 | BP | purine nucleobase metabolic process |
| 957 | skyblue3 | 93 | 3.7e-03 | 1.000 | 18 | GO:0006915 | BP | apoptotic process |
| 958 | skyblue3 | 93 | 4.6e-03 | 1.000 | 2 | GO:0034389 | BP | lipid droplet organization |
| 959 | skyblue3 | 93 | 5.2e-03 | 1.000 | 2 | GO:0022829 | MF | wide pore channel activity |
| 960 | skyblue3 | 93 | 5.5e-03 | 1.000 | 4 | GO:0051015 | MF | actin filament binding |
| 961 | skyblue4 | 42 | 1.6e-04 | 1.000 | 2 | GO:0048563 | BP | post-embryonic animal organ morphogenesis |
| 962 | skyblue4 | 42 | 2.4e-03 | 1.000 | 6 | GO:0043009 | BP | chordate embryonic development |
| 963 | skyblue4 | 42 | 2.8e-03 | 1.000 | 1 | GO:0034263 | BP | positive regulation of autophagy in response to ER overload |
| 964 | skyblue4 | 42 | 2.8e-03 | 1.000 | 1 | GO:0061181 | BP | regulation of chondrocyte development |
| 965 | skyblue4 | 42 | 2.8e-03 | 1.000 | 1 | GO:0070553 | MF | nicotinic acid receptor activity |
| 966 | skyblue4 | 42 | 2.8e-03 | 1.000 | 6 | GO:0009792 | BP | embryo development ending in birth or egg hatching |
| 967 | skyblue4 | 42 | 2.9e-03 | 1.000 | 2 | GO:0048048 | BP | embryonic eye morphogenesis |
| 968 | skyblue4 | 42 | 3.8e-03 | 1.000 | 2 | GO:0032330 | BP | regulation of chondrocyte differentiation |
| 969 | skyblue4 | 42 | 4.7e-03 | 1.000 | 2 | GO:0048483 | BP | autonomic nervous system development |
| 970 | skyblue4 | 42 | 5.6e-03 | 1.000 | 1 | GO:0000290 | BP | deadenylation-dependent decapping of nuclear-transcribed mRNA |
| 971 | steelblue | 114 | 1.1e-03 | 1.000 | 6 | GO:0051321 | BP | meiotic cell cycle |
| 972 | steelblue | 114 | 1.5e-03 | 1.000 | 2 | GO:0003688 | MF | DNA replication origin binding |
| 973 | steelblue | 114 | 1.9e-03 | 1.000 | 2 | GO:0047429 | MF | nucleoside-triphosphate diphosphatase activity |
| 974 | steelblue | 114 | 3.2e-03 | 1.000 | 3 | GO:0050771 | BP | negative regulation of axonogenesis |
| 975 | steelblue | 114 | 3.7e-03 | 1.000 | 5 | GO:0055037 | CC | recycling endosome |
| 976 | steelblue | 114 | 3.7e-03 | 1.000 | 43 | GO:0003824 | MF | catalytic activity |
| 977 | steelblue | 114 | 4.7e-03 | 1.000 | 5 | GO:0016197 | BP | endosomal transport |
| 978 | steelblue | 114 | 4.7e-03 | 1.000 | 5 | GO:0051224 | BP | negative regulation of protein transport |
| 979 | steelblue | 114 | 4.8e-03 | 1.000 | 3 | GO:0043486 | BP | histone exchange |
| 980 | steelblue | 114 | 5.2e-03 | 1.000 | 5 | GO:1904950 | BP | negative regulation of establishment of protein localization |
| 981 | tan | 248 | 2.0e-04 | 1.000 | 26 | GO:0000278 | BP | mitotic cell cycle |
| 982 | tan | 248 | 2.5e-04 | 1.000 | 2 | GO:0004488 | MF | methylenetetrahydrofolate dehydrogenase (NADP+) activity |
| 983 | tan | 248 | 7.0e-04 | 1.000 | 4 | GO:0006298 | BP | mismatch repair |
| 984 | tan | 248 | 8.1e-04 | 1.000 | 4 | GO:0046320 | BP | regulation of fatty acid oxidation |
| 985 | tan | 248 | 1.5e-03 | 1.000 | 2 | GO:0042731 | MF | PH domain binding |
| 986 | tan | 248 | 1.6e-03 | 1.000 | 3 | GO:0046321 | BP | positive regulation of fatty acid oxidation |
| 987 | tan | 248 | 1.6e-03 | 1.000 | 3 | GO:0048103 | BP | somatic stem cell division |
| 988 | tan | 248 | 1.9e-03 | 1.000 | 3 | GO:0031998 | BP | regulation of fatty acid beta-oxidation |
| 989 | tan | 248 | 2.4e-03 | 1.000 | 2 | GO:0036017 | BP | response to erythropoietin |
| 990 | tan | 248 | 2.4e-03 | 1.000 | 2 | GO:0036018 | BP | cellular response to erythropoietin |
| 991 | tan4 | 27 | 3.4e-04 | 1.000 | 3 | GO:0071013 | CC | catalytic step 2 spliceosome |
| 992 | tan4 | 27 | 1.8e-03 | 1.000 | 1 | GO:0030209 | BP | dermatan sulfate catabolic process |
| 993 | tan4 | 27 | 1.8e-03 | 1.000 | 1 | GO:0030211 | BP | heparin catabolic process |
| 994 | tan4 | 27 | 1.8e-03 | 1.000 | 1 | GO:0030393 | BP | fructoselysine metabolic process |
| 995 | tan4 | 27 | 1.8e-03 | 1.000 | 1 | GO:0000250 | MF | lanosterol synthase activity |
| 996 | tan4 | 27 | 1.8e-03 | 1.000 | 1 | GO:0003940 | MF | L-iduronidase activity |
| 997 | tan4 | 27 | 1.8e-03 | 1.000 | 1 | GO:0008894 | MF | guanosine-5’-triphosphate,3’-diphosphate diphosphatase activity |
| 998 | tan4 | 27 | 1.8e-03 | 1.000 | 1 | GO:0030387 | MF | fructosamine-3-kinase activity |
| 999 | tan4 | 27 | 2.2e-03 | 1.000 | 3 | GO:0005681 | CC | spliceosomal complex |
| 1000 | tan4 | 27 | 2.8e-03 | 1.000 | 2 | GO:0012507 | CC | ER to Golgi transport vesicle membrane |
| 1001 | thistle | 48 | 4.6e-04 | 1.000 | 2 | GO:0045059 | BP | positive thymic T cell selection |
| 1002 | thistle | 48 | 1.4e-03 | 1.000 | 2 | GO:0045061 | BP | thymic T cell selection |
| 1003 | thistle | 48 | 2.8e-03 | 1.000 | 2 | GO:2000781 | BP | positive regulation of double-strand break repair |
| 1004 | thistle | 48 | 3.3e-03 | 1.000 | 1 | GO:0030844 | BP | positive regulation of intermediate filament depolymerization |
| 1005 | thistle | 48 | 3.3e-03 | 1.000 | 1 | GO:1990755 | BP | mitotic spindle microtubule depolymerization |
| 1006 | thistle | 48 | 3.3e-03 | 1.000 | 1 | GO:0050265 | MF | RNA uridylyltransferase activity |
| 1007 | thistle | 48 | 3.3e-03 | 1.000 | 1 | GO:0050313 | MF | sulfur dioxygenase activity |
| 1008 | thistle | 48 | 4.0e-03 | 1.000 | 2 | GO:0010569 | BP | regulation of double-strand break repair via homologous recombination |
| 1009 | thistle | 48 | 4.0e-03 | 1.000 | 2 | GO:0043368 | BP | positive T cell selection |
| 1010 | thistle | 48 | 6.5e-03 | 1.000 | 1 | GO:0045105 | BP | intermediate filament polymerization or depolymerization |
| 1011 | thistle1 | 82 | 5.5e-05 | 0.970 | 7 | GO:0051054 | BP | positive regulation of DNA metabolic process |
| 1012 | thistle1 | 82 | 8.2e-05 | 1.000 | 2 | GO:0051032 | MF | nucleic acid transmembrane transporter activity |
| 1013 | thistle1 | 82 | 8.2e-05 | 1.000 | 2 | GO:0051033 | MF | RNA transmembrane transporter activity |
| 1014 | thistle1 | 82 | 7.5e-04 | 1.000 | 2 | GO:0006559 | BP | L-phenylalanine catabolic process |
| 1015 | thistle1 | 82 | 1.4e-03 | 1.000 | 4 | GO:0006304 | BP | DNA modification |
| 1016 | thistle1 | 82 | 1.4e-03 | 1.000 | 75 | GO:0003674 | MF | molecular_function |
| 1017 | thistle1 | 82 | 1.5e-03 | 1.000 | 2 | GO:0061578 | MF | Lys63-specific deubiquitinase activity |
| 1018 | thistle1 | 82 | 2.2e-03 | 1.000 | 3 | GO:0030971 | MF | receptor tyrosine kinase binding |
| 1019 | thistle1 | 82 | 2.4e-03 | 1.000 | 2 | GO:0006349 | BP | regulation of gene expression by genetic imprinting |
| 1020 | thistle1 | 82 | 2.5e-03 | 1.000 | 3 | GO:0045739 | BP | positive regulation of DNA repair |
| 1021 | thistle2 | 75 | 2.2e-03 | 1.000 | 2 | GO:0005540 | MF | hyaluronic acid binding |
| 1022 | thistle2 | 75 | 2.5e-03 | 1.000 | 2 | GO:0010485 | MF | H4 histone acetyltransferase activity |
| 1023 | thistle2 | 75 | 4.8e-03 | 1.000 | 3 | GO:0070542 | BP | response to fatty acid |
| 1024 | thistle2 | 75 | 5.0e-03 | 1.000 | 3 | GO:0016410 | MF | N-acyltransferase activity |
| 1025 | thistle2 | 75 | 5.0e-03 | 1.000 | 1 | GO:0019442 | BP | tryptophan catabolic process to acetyl-CoA |
| 1026 | thistle2 | 75 | 5.0e-03 | 1.000 | 1 | GO:0034156 | BP | negative regulation of toll-like receptor 7 signaling pathway |
| 1027 | thistle2 | 75 | 5.0e-03 | 1.000 | 1 | GO:0034427 | BP | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3’-5’ |
| 1028 | thistle2 | 75 | 5.0e-03 | 1.000 | 1 | GO:0034516 | BP | response to vitamin B6 |
| 1029 | thistle2 | 75 | 5.0e-03 | 1.000 | 1 | GO:0070413 | BP | trehalose metabolism in response to stress |
| 1030 | thistle2 | 75 | 5.0e-03 | 1.000 | 1 | GO:0070543 | BP | response to linoleic acid |
| 1031 | thistle3 | 53 | 3.4e-05 | 0.590 | 2 | GO:0004464 | MF | leukotriene-C4 synthase activity |
| 1032 | thistle3 | 53 | 1.7e-04 | 1.000 | 2 | GO:0016846 | MF | carbon-sulfur lyase activity |
| 1033 | thistle3 | 53 | 6.9e-04 | 1.000 | 3 | GO:0006400 | BP | tRNA modification |
| 1034 | thistle3 | 53 | 8.6e-04 | 1.000 | 3 | GO:0071242 | BP | cellular response to ammonium ion |
| 1035 | thistle3 | 53 | 8.6e-04 | 1.000 | 2 | GO:1902187 | BP | negative regulation of viral release from host cell |
| 1036 | thistle3 | 53 | 1.0e-03 | 1.000 | 2 | GO:0007213 | BP | G protein-coupled acetylcholine receptor signaling pathway |
| 1037 | thistle3 | 53 | 1.7e-03 | 1.000 | 2 | GO:0072012 | BP | glomerulus vasculature development |
| 1038 | thistle3 | 53 | 1.9e-03 | 1.000 | 2 | GO:0045296 | MF | cadherin binding |
| 1039 | thistle3 | 53 | 2.1e-03 | 1.000 | 2 | GO:0030488 | BP | tRNA methylation |
| 1040 | thistle3 | 53 | 2.3e-03 | 1.000 | 2 | GO:0095500 | BP | acetylcholine receptor signaling pathway |
| 1041 | thistle4 | 31 | 1.5e-06 | 0.026 | 3 | GO:0040037 | BP | negative regulation of fibroblast growth factor receptor signaling pathway |
| 1042 | thistle4 | 31 | 1.8e-05 | 0.310 | 3 | GO:0040036 | BP | regulation of fibroblast growth factor receptor signaling pathway |
| 1043 | thistle4 | 31 | 8.4e-05 | 1.000 | 4 | GO:0090288 | BP | negative regulation of cellular response to growth factor stimulus |
| 1044 | thistle4 | 31 | 1.2e-04 | 1.000 | 2 | GO:0035457 | BP | cellular response to interferon-alpha |
| 1045 | thistle4 | 31 | 1.2e-04 | 1.000 | 2 | GO:0035860 | BP | glial cell-derived neurotrophic factor receptor signaling pathway |
| 1046 | thistle4 | 31 | 2.4e-04 | 1.000 | 2 | GO:2000615 | BP | regulation of histone H3-K9 acetylation |
| 1047 | thistle4 | 31 | 3.5e-04 | 1.000 | 2 | GO:0043970 | BP | histone H3-K9 acetylation |
| 1048 | thistle4 | 31 | 3.5e-04 | 1.000 | 17 | GO:0048731 | BP | system development |
| 1049 | thistle4 | 31 | 6.7e-04 | 1.000 | 2 | GO:0035455 | BP | response to interferon-alpha |
| 1050 | thistle4 | 31 | 9.4e-04 | 1.000 | 3 | GO:0008543 | BP | fibroblast growth factor receptor signaling pathway |
| 1051 | turquoise | 1458 | 4.6e-05 | 0.810 | 6 | GO:0005687 | CC | U4 snRNP |
| 1052 | turquoise | 1458 | 1.1e-04 | 1.000 | 6 | GO:0005685 | CC | U1 snRNP |
| 1053 | turquoise | 1458 | 8.5e-04 | 1.000 | 3 | GO:0003331 | BP | positive regulation of extracellular matrix constituent secretion |
| 1054 | turquoise | 1458 | 1.0e-03 | 1.000 | 4 | GO:0005683 | CC | U7 snRNP |
| 1055 | turquoise | 1458 | 1.3e-03 | 1.000 | 5 | GO:0070278 | BP | extracellular matrix constituent secretion |
| 1056 | turquoise | 1458 | 2.1e-03 | 1.000 | 5 | GO:0034709 | CC | methylosome |
| 1057 | turquoise | 1458 | 3.1e-03 | 1.000 | 3 | GO:1900069 | BP | regulation of cellular hyperosmotic salinity response |
| 1058 | turquoise | 1458 | 3.1e-03 | 1.000 | 3 | GO:1905908 | BP | positive regulation of amyloid fibril formation |
| 1059 | turquoise | 1458 | 3.1e-03 | 1.000 | 3 | GO:0016013 | CC | syntrophin complex |
| 1060 | turquoise | 1458 | 3.1e-03 | 1.000 | 3 | GO:0005534 | MF | galactose binding |
| 1061 | violet | 109 | 1.1e-03 | 1.000 | 2 | GO:0001866 | BP | NK T cell proliferation |
| 1062 | violet | 109 | 1.8e-03 | 1.000 | 3 | GO:0032212 | BP | positive regulation of telomere maintenance via telomerase |
| 1063 | violet | 109 | 2.1e-03 | 1.000 | 3 | GO:1904358 | BP | positive regulation of telomere maintenance via telomere lengthening |
| 1064 | violet | 109 | 2.3e-03 | 1.000 | 2 | GO:0032688 | BP | negative regulation of interferon-beta production |
| 1065 | violet | 109 | 2.3e-03 | 1.000 | 2 | GO:1902916 | BP | positive regulation of protein polyubiquitination |
| 1066 | violet | 109 | 2.4e-03 | 1.000 | 3 | GO:0090311 | BP | regulation of protein deacetylation |
| 1067 | violet | 109 | 2.6e-03 | 1.000 | 4 | GO:1903076 | BP | regulation of protein localization to plasma membrane |
| 1068 | violet | 109 | 2.7e-03 | 1.000 | 9 | GO:0048667 | BP | cell morphogenesis involved in neuron differentiation |
| 1069 | violet | 109 | 2.8e-03 | 1.000 | 3 | GO:0032648 | BP | regulation of interferon-beta production |
| 1070 | violet | 109 | 3.3e-03 | 1.000 | 3 | GO:0032608 | BP | interferon-beta production |
| 1071 | white | 120 | 1.8e-04 | 1.000 | 2 | GO:0015277 | MF | kainate selective glutamate receptor activity |
| 1072 | white | 120 | 1.8e-04 | 1.000 | 2 | GO:0099507 | MF | ligand-gated ion channel activity involved in regulation of presynaptic membrane potential |
| 1073 | white | 120 | 6.8e-04 | 1.000 | 4 | GO:0006801 | BP | superoxide metabolic process |
| 1074 | white | 120 | 7.1e-04 | 1.000 | 3 | GO:0085029 | BP | extracellular matrix assembly |
| 1075 | white | 120 | 8.7e-04 | 1.000 | 2 | GO:0099505 | BP | regulation of presynaptic membrane potential |
| 1076 | white | 120 | 1.2e-03 | 1.000 | 2 | GO:1901201 | BP | regulation of extracellular matrix assembly |
| 1077 | white | 120 | 1.2e-03 | 1.000 | 2 | GO:0030023 | MF | extracellular matrix constituent conferring elasticity |
| 1078 | white | 120 | 1.3e-03 | 1.000 | 3 | GO:0005272 | MF | sodium channel activity |
| 1079 | white | 120 | 1.6e-03 | 1.000 | 2 | GO:0008228 | BP | opsonization |
| 1080 | white | 120 | 1.6e-03 | 1.000 | 2 | GO:0060363 | BP | cranial suture morphogenesis |
| 1081 | yellow | 716 | 5.1e-05 | 0.890 | 58 | GO:0014070 | BP | response to organic cyclic compound |
| 1082 | yellow | 716 | 9.3e-05 | 1.000 | 31 | GO:0001228 | MF | DNA-binding transcription activator activity, RNA polymerase II-specific |
| 1083 | yellow | 716 | 1.3e-04 | 1.000 | 5 | GO:0048311 | BP | mitochondrion distribution |
| 1084 | yellow | 716 | 1.3e-04 | 1.000 | 5 | GO:1900402 | BP | regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter |
| 1085 | yellow | 716 | 1.4e-04 | 1.000 | 88 | GO:0006508 | BP | proteolysis |
| 1086 | yellow | 716 | 1.5e-04 | 1.000 | 4 | GO:0048312 | BP | intracellular distribution of mitochondria |
| 1087 | yellow | 716 | 2.0e-04 | 1.000 | 55 | GO:0033993 | BP | response to lipid |
| 1088 | yellow | 716 | 2.4e-04 | 1.000 | 10 | GO:0032922 | BP | circadian regulation of gene expression |
| 1089 | yellow | 716 | 3.7e-04 | 1.000 | 29 | GO:0048545 | BP | response to steroid hormone |
| 1090 | yellow | 716 | 3.7e-04 | 1.000 | 39 | GO:0071396 | BP | cellular response to lipid |
| 1091 | yellow3 | 38 | 7.9e-04 | 1.000 | 3 | GO:0031124 | BP | mRNA 3’-end processing |
| 1092 | yellow3 | 38 | 1.2e-03 | 1.000 | 3 | GO:0031123 | BP | RNA 3’-end processing |
| 1093 | yellow3 | 38 | 1.3e-03 | 1.000 | 3 | GO:0043021 | MF | ribonucleoprotein complex binding |
| 1094 | yellow3 | 38 | 1.4e-03 | 1.000 | 3 | GO:0006406 | BP | mRNA export from nucleus |
| 1095 | yellow3 | 38 | 1.7e-03 | 1.000 | 2 | GO:0016878 | MF | acid-thiol ligase activity |
| 1096 | yellow3 | 38 | 1.9e-03 | 1.000 | 3 | GO:0071166 | BP | ribonucleoprotein complex localization |
| 1097 | yellow3 | 38 | 2.2e-03 | 1.000 | 3 | GO:0006405 | BP | RNA export from nucleus |
| 1098 | yellow3 | 38 | 2.4e-03 | 1.000 | 1 | GO:0006617 | BP | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition |
| 1099 | yellow3 | 38 | 2.4e-03 | 1.000 | 1 | GO:0046778 | BP | modification by virus of host mRNA processing |
| 1100 | yellow3 | 38 | 2.4e-03 | 1.000 | 1 | GO:0070966 | BP | nuclear-transcribed mRNA catabolic process, no-go decay |
| 1101 | yellow4 | 64 | 1.1e-04 | 1.000 | 3 | GO:0008009 | MF | chemokine activity |
| 1102 | yellow4 | 64 | 2.7e-04 | 1.000 | 4 | GO:0035710 | BP | CD4-positive, alpha-beta T cell activation |
| 1103 | yellow4 | 64 | 4.6e-04 | 1.000 | 5 | GO:0001664 | MF | G protein-coupled receptor binding |
| 1104 | yellow4 | 64 | 5.3e-04 | 1.000 | 3 | GO:0042379 | MF | chemokine receptor binding |
| 1105 | yellow4 | 64 | 8.0e-04 | 1.000 | 2 | GO:0010820 | BP | positive regulation of T cell chemotaxis |
| 1106 | yellow4 | 64 | 9.1e-04 | 1.000 | 7 | GO:0042110 | BP | T cell activation |
| 1107 | yellow4 | 64 | 9.8e-04 | 1.000 | 2 | GO:0010819 | BP | regulation of T cell chemotaxis |
| 1108 | yellow4 | 64 | 1.2e-03 | 1.000 | 2 | GO:0071880 | BP | adenylate cyclase-activating adrenergic receptor signaling pathway |
| 1109 | yellow4 | 64 | 1.5e-03 | 1.000 | 4 | GO:0046631 | BP | alpha-beta T cell activation |
| 1110 | yellow4 | 64 | 1.8e-03 | 1.000 | 2 | GO:0001916 | BP | positive regulation of T cell mediated cytotoxicity |
| 1111 | yellowgreen | 98 | 4.1e-04 | 1.000 | 2 | GO:0008199 | MF | ferric iron binding |
| 1112 | yellowgreen | 98 | 6.0e-04 | 1.000 | 8 | GO:0031267 | MF | small GTPase binding |
| 1113 | yellowgreen | 98 | 1.4e-03 | 1.000 | 2 | GO:0003756 | MF | protein disulfide isomerase activity |
| 1114 | yellowgreen | 98 | 1.5e-03 | 1.000 | 12 | GO:0030234 | MF | enzyme regulator activity |
| 1115 | yellowgreen | 98 | 1.6e-03 | 1.000 | 3 | GO:0003954 | MF | NADH dehydrogenase activity |
| 1116 | yellowgreen | 98 | 1.6e-03 | 1.000 | 3 | GO:0008137 | MF | NADH dehydrogenase (ubiquinone) activity |
| 1117 | yellowgreen | 98 | 1.7e-03 | 1.000 | 4 | GO:0016651 | MF | oxidoreductase activity, acting on NAD(P)H |
| 1118 | yellowgreen | 98 | 1.8e-03 | 1.000 | 2 | GO:0009263 | BP | deoxyribonucleotide biosynthetic process |
| 1119 | yellowgreen | 98 | 2.2e-03 | 1.000 | 2 | GO:0060670 | BP | branching involved in labyrinthine layer morphogenesis |
| 1120 | yellowgreen | 98 | 2.2e-03 | 1.000 | 2 | GO:0032797 | CC | SMN complex |
Xarxa cytoscape
Factors de transcripció tots els mòduls associats
Factors de transcripció mòduls per separat
resultsSubset_deeppink.csv
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | geneSet | predrem__nrMotif2025 | 4.47 | 0.0706 | 26 | 976 | ABCC2;ARCN1;CAMKK1;CPNE4;DLG3;DNAH11;EFNB1;FSIP1;GSN;IGFBPL1;KCNT1;LUZP1;PIK3C2B;PRSS23;RGS4;RXFP1;SEL1L3;SIPA1L1;SLC12A6;SLC30A7;SLC45A3;SLC9A1;TMEM170B;UBR1;USP9X;ZNF560 | |||
| 2 | geneSet | hocomoco__RUNX3_HUMAN.H11MO.0.A | 4.44 | 0.0704 | RUNX3 (directAnnotation). | BCL11A; CBFB; CEBPB; EP300; FOXM1; IKZF1; MTA3; NFATC1; NFIC; RUNX1; RUNX2; STAT3; STAT5A; TBL1XR1 (inferredBy_MotifSimilarity). | 14 | 314 | ATP13A2;DMWD;GSN;LARGE;MAGI1;NCKAP5;PIK3C2B;PRPF40B;PRSS23;RALGPS2;SH3YL1;SLC30A7;SNX9;XCL2 | |
| 3 | geneSet | transfac_pro__M06524 | 4.35 | 0.0695 | ZNF721 (directAnnotation). | 16 | 394 | ABCC2;ATF7IP;C6orf62;FOXD3;FSIP1;MAGI1;NCKAP5;PRPF40B;PRSS23;RXFP1;SLC45A3;TNMD;UBA5;USP9X;XCL2;ZCCHC2 | ||
| 4 | geneSet | transfac_pro__M05766 | 4.28 | 0.0689 | ZNF667 (directAnnotation). | 26 | 1157 | ADORA3;APOL3;ARRDC2;ATF7IP;ATXN10;CPS1;EFNB1;GLRA2;HPSE2;JAK2;LIPA;LRIG2;NCKAP5;PHTF1;PRSS23;PSMC6;RAI2;RASAL2;SLC25A26;SLC30A7;SLC45A3;SNAP23;SNCA;SNX9;UBA5;VPS53 | ||
| 5 | geneSet | dbcorrdb__ZNF274__ENCSR000EVX_1__m1 | 4.26 | 0.0687 | ZNF274 (directAnnotation). | TRIM28 (inferredBy_MotifSimilarity). | 40 | 2264 | ADORA3;ANGPT2;ATG16L1;BTK;CDC42EP3;CHRNB4;CPNE4;CPS1;DDX60L;ERMP1;FSIP1;GALNT6;GLRA2;JAK2;KIAA1211;KLHL1;KLHL20;LARGE;LIPA;LUZP1;MSR1;MYH2;PELI2;PRIM2;PRSS23;PRTFDC1;RAI2;RASAL2;RXFP1;SEPT7;SIPA1L1;SLC12A6;SLC39A10;SLC45A3;SNX9;SPPL3;TNMD;UNC5B;ZCCHC2;ZNF501 | |
| 6 | geneSet | predrem__nrMotif2318 | 4.24 | 0.0685 | 12 | 225 | ABCC2;ASB4;BTK;CPNE4;CPS1;EEFSEC;KIAA1211;MAGI1;NXPH3;PTPRN2;RHOV;UNC5B | |||
| 7 | geneSet | stark__CMGGAAR | 4.20 | 0.0681 | ELF1; ELF2; ELF4 (inferredBy_Orthology). | ELK3; ERG; FLI1 (inferredBy_MotifSimilarity). | 25 | 993 | ARHGEF1;ATG16L1;CAMKK1;CDC42EP3;EFNB1;FSIP1;ITGA2;JAK2;KCNT1;KLHL20;LPIN2;LUZP1;MLN;NXPH3;PIK3C2B;PRSS23;RNF167;SEL1L3;SEPT7;SLC12A6;SLC30A7;SLC9A1;TRAPPC4;UNC5B;ZNF75D | |
| 8 | geneSet | predrem__nrMotif2415 | 4.17 | 0.0679 | 30 | 1407 | ABCC2;ATF7IP;CDC42EP3;CPNE4;FCHO2;FOXD3;FSIP1;GABRA3;GALNT6;JAK2;KLHL1;KLHL20;KLHL28;LUZP1;MYH2;PELI2;PIK3C2B;PKMYT1;PRSS23;RASA3;RASAL2;RXFP1;SIPA1L1;SLC45A3;TNMD;TOM1L2;USP9X;VPS26B;XCL2;XRCC5 | |||
| 9 | geneSet | taipale_tf_pairs__FLI1_DRGX_NNCGGAWGYMATTAN_CAP | 4.15 | 0.0677 | DRGX; FLI1 (directAnnotation). | 75 | 4963 | ABCB1;ANGPT2;APOL3;ATF7IP;ATG16L1;BCAM;BRWD1;BTK;CAMKK1;CPNE4;CPS1;DLG3;EEFSEC;EFNB1;FOXD3;FSIP1;GABRA3;GALNT6;GRK6;HDLBP;HPSE2;IGFBPL1;ITGA2;JAK2;KCNT1;KIAA0319L;KIAA1211;KLHL1;KLHL20;LARGE;LIPA;LMBR1;LPIN2;LUZP1;MLN;MNAT1;MSR1;MYH2;MYO1H;NAA35;NFKB1;NXPH3;PELI2;PIK3C2B;PRPF40B;PRSS23;PRTFDC1;RAI2;RALGPS2;RASAL2;RGS4;RNF167;RNMT;RXFP1;SEL1L3;SEPT7;SH3YL1;SIPA1L1;SLC12A6;SLC25A26;SLC30A7;SLC45A3;SPPL3;TECPR1;TNMD;TRAPPC4;UBA5;UNC5B;USP9X;XCL2;YME1L1;ZBTB25;ZCCHC2;ZKSCAN5;ZNF75D | ||
| 10 | geneSet | c2h2_zfs__M4447 | 4.13 | 0.0676 | BCL6B (directAnnotation). | BCL6 (inferredBy_MotifSimilarity). | 19 | 746 | ARCN1;ATXN10;CPNE4;CYP20A1;DDX60L;EIF3A;FOXD3;KLHL1;LPIN2;MYH2;NFKB1;NXPH3;PELI2;RALGPS2;RASAL2;SLC45A3;TCP11L1;UBA5;ZKSCAN5 |
resultsSubset_magenta4.csv
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | geneSet | transfac_pro__M04927 | 5.56 | 0.148 | FOXA1 (directAnnotation). | 7 | 535 | CARD10;CDC42EP3;CPS1;GALNT6;PGM2L1;PKMYT1;SEPT7 | ||
| 2 | geneSet | transfac_pro__M07909 | 5.33 | 0.143 | OSR1; OSR2 (inferredBy_Orthology). | 9 | 1670 | CDC42EP3;ERMP1;GALNT6;GSN;NAA35;SEPT7;SLC9A1;TNMD;TRAPPC4 | ||
| 3 | geneSet | taipale_tf_pairs__ELK1_TBX21_RAGGTSRNNNNNNNNNNNNNNNNCGGAAGYN_CAP | 5.31 | 0.142 | ELK1; TBX21 (directAnnotation). | 7 | 830 | CDC42EP3;CPS1;LARGE;NAA35;PGM2L1;SEPT7;TECPR1 | ||
| 4 | geneSet | transfac_pro__M05167 | 5.18 | 0.140 | 11 | 2492 | C6orf62;CCDC50;CDC42EP3;GSN;LARGE;PGM2L1;PSG2;SEPT7;SPPL3;UROC1;ZKSCAN5 | |||
| 5 | geneSet | predrem__nrMotif1541 | 4.91 | 0.134 | 5 | 397 | CDC42EP3;CPS1;GSN;SEPT7;SPPL3 | |||
| 6 | geneSet | transfac_pro__M05981 | 4.91 | 0.134 | ZNF233 (directAnnotation). | 6 | 535 | C6orf62;CDC42EP3;GSN;PKMYT1;SH3YL1;UROC1 | ||
| 7 | geneSet | transfac_pro__M01620 | 4.70 | 0.129 | 6 | 546 | C6orf62;CDC42EP3;GALNT6;LARGE;NAA35;ZKSCAN5 | |||
| 8 | geneSet | jaspar__MA0392.1 | 4.65 | 0.128 | 6 | 601 | C6orf62;CDC42EP3;GALNT6;LARGE;NAA35;ZKSCAN5 | |||
| 9 | geneSet | hocomoco__PITX1_HUMAN.H11MO.0.D | 4.60 | 0.127 | PITX1 (directAnnotation). | OTX1; OTX2; PITX3 (inferredBy_MotifSimilarity). PITX2 (inferredBy_MotifSimilarity_n_Orthology). | 4 | 201 | C6orf62;CPS1;GALNT6;PSG2 | |
| 10 | geneSet | dbcorrdb__EZH2__ENCSR000ASZ_1__m3 | 4.59 | 0.127 | EZH2 (directAnnotation). | 5 | 381 | C6orf62;CCDC50;CDC42EP3;LARGE;SEPT7 |
resultsSubset_saddlebrown.csv
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | geneSet | taipale_cyt_meth__TFCP2L1_NCCGGNNNNNNCCGGN_eDBD_meth | 5.76 | 0.124 | TFCP2L1 (directAnnotation). | TFCP2; UBP1 (inferredBy_MotifSimilarity). | 7 | 540 | ATF7IP;BCAM;FSIP1;ITGA2;KLHL20;RHOV;SIPA1L1 | |
| 2 | geneSet | taipale_cyt_meth__TFCP2L1_NCCGGNNNNNNCCGGN_eDBD | 5.69 | 0.123 | TFCP2L1 (directAnnotation). | TFCP2; UBP1 (inferredBy_MotifSimilarity). | 7 | 464 | ATF7IP;BCAM;FSIP1;ITGA2;KLHL20;RHOV;SIPA1L1 | |
| 3 | geneSet | taipale_cyt_meth__MYOD1_NAACANNTGTYN_FL | 5.63 | 0.122 | MYOD1 (directAnnotation). | ATOH1; BHLHA15; FERD3L; MSC; MYF6; MYOG; OLIG2; OLIG3; TCF21 (inferredBy_MotifSimilarity). ASCL2; MYF5 (inferredBy_MotifSimilarity_n_Orthology). | 8 | 833 | BCAM;CYP4A22;DDX60L;FSIP1;HSPB7;KIAA0319L;RASA3;TTC17 | |
| 4 | geneSet | taipale_tf_pairs__ETV2_HOXA2_NCCGGAAGNNNNNNYMATTA_CAP | 5.31 | 0.117 | ETV2; HOXA2 (directAnnotation). | 8 | 794 | DLG3;FSIP1;HDLBP;ITGA2;RASA3;SEL1L3;SIPA1L1;YME1L1 | ||
| 5 | geneSet | taipale_cyt_meth__MYOD1_NAACANNTGTYN_eDBD | 5.30 | 0.116 | MYOD1 (directAnnotation). | ATOH1; BHLHA15; FERD3L; MSC; MYF6; MYOG; OLIG2; TCF21; TFAP4 (inferredBy_MotifSimilarity). ASCL2; MYF5 (inferredBy_MotifSimilarity_n_Orthology). | 7 | 642 | BCAM;DDX60L;FSIP1;HSPB7;KIAA0319L;RASA3;TTC17 | |
| 6 | geneSet | taipale_cyt_meth__MYOD1_NAACANNTGTYN_FL_meth | 5.25 | 0.115 | MYOD1 (directAnnotation). | ATOH1; BHLHA15; FERD3L; MSC; MYF6; MYOG; OLIG2; OLIG3; TCF21 (inferredBy_MotifSimilarity). ASCL2; MYF5 (inferredBy_MotifSimilarity_n_Orthology). | 9 | 1367 | BCAM;CYP4A22;DDX60L;FSIP1;HSPB7;KIAA0319L;RASA3;SIPA1L1;TTC17 | |
| 7 | geneSet | taipale_tf_pairs__ERF_HOXA3_RSCGGAWNNNNNNNYMATTA_CAP_repr | 5.24 | 0.115 | ERF; HOXA3 (directAnnotation). | 11 | 1591 | DLG3;FSIP1;FURIN;HDLBP;ITGA2;KRT13;RASA3;SEL1L3;SIPA1L1;TTC17;YME1L1 | ||
| 8 | geneSet | dbcorrdb__POLR2A__ENCSR000AKZ_1__m3 | 5.16 | 0.114 | POLR2A (directAnnotation). | 8 | 1071 | ATXN10;DLG3;GABRA3;PIK3CB;RGS4;SEL1L3;SIPA1L1;TTC17 | ||
| 9 | geneSet | taipale_cyt_meth__MYF6_NAACANNTGWYN_eDBD | 4.95 | 0.110 | MYF6 (directAnnotation). | ATOH1; MSC; MYOD1; MYOG; PTF1A; TCF21 (inferredBy_MotifSimilarity). MYF5 (inferredBy_MotifSimilarity_n_Orthology). | 5 | 264 | BCAM;DDX60L;KIAA0319L;RASA3;TTC17 | |
| 10 | geneSet | taipale_cyt_meth__MYOD1_NAACANNTGTYN_eDBD_meth | 4.86 | 0.109 | MYOD1 (directAnnotation). | ATOH1; BHLHA15; FERD3L; MSC; MYF6; MYOG; OLIG2; OLIG3; TCF21 (inferredBy_MotifSimilarity). ASCL2; MYF5 (inferredBy_MotifSimilarity_n_Orthology). | 11 | 1754 | BCAM;CYP4A22;DDX60L;FSIP1;HSPB7;KIAA0319L;RASA3;SEL1L3;SIPA1L1;TTC17;ZKSCAN2 |
NA
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | geneSet | transfac_pro__M05766 | 5.81 | 0.1010 | ZNF667 (directAnnotation). | 18 | 683 | ADORA3;APOL3;EFNB1;HPSE2;JAK2;LRIG2;NCKAP5;PHTF1;PRSS23;PSMC6;RAI2;RASAL2;SLC25A26;SLC30A7;SLC45A3;SNCA;SNX9;VPS53 | ||
| 2 | geneSet | c2h2_zfs__M4447 | 4.66 | 0.0878 | BCL6B (directAnnotation). | BCL6 (inferredBy_MotifSimilarity). | 15 | 746 | CPNE4;CYP20A1;EIF3A;FOXD3;KLHL1;LPIN2;MYH2;NFKB1;NXPH3;PELI2;RALGPS2;RASAL2;SLC45A3;TCP11L1;UBA5 | |
| 3 | geneSet | predrem__nrMotif2318 | 4.53 | 0.0862 | 11 | 350 | ASB4;BTK;CPNE4;EEFSEC;EFNB1;KIAA1211;MAGI1;NXPH3;PTPRN2;UNC5B;ZNF501 | |||
| 4 | geneSet | predrem__nrMotif723 | 4.52 | 0.0861 | 39 | 3397 | ANGPT2;ARHGAP42;BTK;CAMKK1;CPNE4;EFNB1;FCHO2;GDPD1;HPSE2;JAK2;KLHL1;LIPA;LIX1;LPIN2;LRIG2;LUZP1;LYSMD4;MAGI1;MSR1;MYH2;NCKAP5;NFKB1;NXPH3;PIK3C2B;PRSS23;RAI2;RALGPS2;RXFP1;SLC25A26;SLC30A7;SLC45A3;TMEM170B;UBA5;UBR1;UNC5B;USP9X;XRCC5;ZBTB25;ZCCHC2 | |||
| 5 | geneSet | cisbp__M2261 | 4.44 | 0.0851 | FOXC2; FOXF2; FOXG1; FOXI1; FOXJ3; FOXK1; FOXL2; FOXO3; FOXO4 (inferredBy_MotifSimilarity). FOXC1; FOXF1; FOXO1; FOXP1; FOXP2; FOXP3; FOXP4; FOXS1 (inferredBy_MotifSimilarity_n_Orthology). | 17 | 891 | ANGPT2;CAMKK1;FCHO2;FOXD3;MAGI1;MLN;MNAT1;NCKAP5;PELI2;PRSS23;RAI2;RALGPS2;RXFP1;SLC25A26;SLC39A10;UNC5B;USP9X | ||
| 6 | geneSet | transfac_pro__M06648 | 4.41 | 0.0848 | ZNF607 (directAnnotation). | 18 | 1061 | ACSS1;ADORA3;ANGPT2;APOL3;BTK;LYSMD4;MLN;NBPF4;PHTF1;RAI2;RALGPS2;RASAL2;SCLT1;SCRIB;SLC25A26;SLC39A10;UNC5B;USP9X | ||
| 7 | geneSet | taipale_tf_pairs__ELK1_FOXI1_RSCGGAANRTMAAYA_CAP_repr | 4.28 | 0.0833 | ELK1; FOXI1 (directAnnotation). | 14 | 752 | ANGPT2;BTK;CAMKK1;MAGI1;NCKAP5;NXPH3;PELI2;PRSS23;RAI2;RALGPS2;SLC12A6;SLC39A10;USP9X;ZBTB25 | ||
| 8 | geneSet | predrem__nrMotif1015 | 4.23 | 0.0827 | 20 | 1152 | ADORA3;ANGPT2;BTK;CPNE4;EFNB1;HNRNPAB;LIPA;LUZP1;MYH2;PRSS23;RALGPS2;RASAL2;RXFP1;SLC30A7;SLC39A10;SNX9;TRAK1;USP9X;ZBTB25;ZCCHC2 | |||
| 9 | geneSet | hocomoco__MYCN_MOUSE.H11MO.0.A | 4.13 | 0.0814 | MYCN (inferredBy_Orthology). | MAX; MXI1; MYC (inferredBy_MotifSimilarity). | 13 | 578 | ACSS1;ANGPT2;CAMKK1;HPSE2;KCNT1;MYL10;NCKAP5;PSMC6;PTPRN2;RAI2;RNH1;SLC39A10;ZCCHC2 | |
| 10 | geneSet | cisbp__M3382 | 4.12 | 0.0814 | FOXD3; FOXF1; FOXF2; FOXH1; FOXJ1; FOXQ1 (inferredBy_MotifSimilarity). FOXD1; FOXD2; FOXD4; FOXD4L1; FOXD4L3; FOXD4L4; FOXD4L5; FOXD4L6 (inferredBy_MotifSimilarity_n_Orthology). | 16 | 908 | CPNE4;CYP20A1;EFNB1;MRPS9;NCKAP5;PELI2;PIK3C2B;PTPRN2;RAI2;RALGPS2;SLC12A6;SLC25A26;SLC45A3;SNX9;UNC5B;USP9X |